csr in the pharmaceutical industry : the case study of novo nordisk
Post on 11-Feb-2018
221 Views
Preview:
TRANSCRIPT
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
1/77
>3>59?6
4
Jldptcr 4 Obtraeujtoab
4"4 Ycscdrjl Idj`mraube
Ulc pldrgdjcutojdk obeustry os ubko`c gdby atlcr obeustrocs+ euc ta ots bdturc af
iusobcss tldt erums jdb ic rcgceocs far kofc'tlrcdtcbobm okkbcsscs" Icjdusc af tlos
jcrtdob bdturc tldt os dttdjlce ta tlos obeustry+ ot os jabsoecrce ta ldvc d kdrmc ctlojdk
rcspabsoiokoty tawdres tlc puikoj+ far cxdgpkc+ pravoeobm dffaredikc erums ta tlasc
wla bcce ot"
Ot sccgs ds of tlc pldrgdjcutojdk obeustry lds d jabsoecrdikc obtcrcst ta war` ab ots
JZY" ,Bussidug+ 9>>? p "6?/ Ot jdb ic sccb tldt tlc rcdsab jagpdbocs ea tlc romlt
tlobm drc aftcb pcrjcovce ds strdtcmoj+ ecfcbsovc+ dbe puikoj 'sporotce"
Ds JZY os bat d abc'wdy rade+ JZY djtoabs jdb ldvc prafaube ,pasotovc/ cffcjts ab
tlc jagpdby dt tlcor aromob" ,@atkcr dbe Kcc 9>>3+ jotce iy Bussidug 9>>< p"6?/
Obtcmrdtobm JZY jdb tlcrcfarc iuoke d strabmcr rcputdtoab+ dttrdjt dbe rctdob d
gatovdtce war`farjc+ iuoke d strabm jagguboty rckdtoabslop+ dbe rceujc rcmukdtary
avcrsomlt"
Ulc gast farwdre'kaa`obm farg af JZY os cbmdmobm ds d iusobcss ob sajodk
rcspabsoikc iusobcss prdjtoscs" Ulcsc vakubtdry jarpardtc iusobcss prdjtoscs ar
obvcstgcbts ta suppart sajodk jduscs jdb ldvc jabscqucbjcs ab tlc iusobcss
gaeck otsckf" ,Bussidug+ 9>>?+ p"6?/
Ulos pdrtojukdr dppradjl ta JZY gomlt ic cspcjodkky dedptce ta deercss tlc
pldrgdjcutojdk obeustrys gardk ogpartdbjc ta pravoec lckp far tlasc wla drc ob
bcce"Jagpdbocs wla bcmkcjt tlcor rcspabsoikc iusobcss djtovotocs jdb icjagc db cdsy
tdrmct iy tlc prcss dbe jabsugcr mraups" Kcofcivrc dbe Gokkcr ,9>>6/ gcbtoab tldt
pldrgdjcutojdks ldvc d gardk aikomdtoab ta sajocty dbe ta pravoec sajocty wotl
dffaredikc erums" ,Kcofcivrc dbe Gokkcr+ 9>>6+jotce iy Bussidug+ 9>>?+ p"6
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
2/77
>3>59?6
9
Ulc jarpardtc jrotojdk rcscdrjl mraup Jarpardtc ]dtjl puikoslce d kost af jrogcs
frag tlc pldrgdjcutojdk scjtar+ tlcsc objkuece8 loml projcs+ didbeabobm tlc paar+
oggardk gdr`ctobm jdgpdombs+ dbe ldvobm d ba gabcy ba jurc dttotuec" Jarpardtc
]dtjl ikdgcs tlc pldrgdjcutojdk obeustry far prdjtojobm ds ot kdicks+ jarpardtcoblugdboty"
Ulc dutlars Fobcmake ct dk"+ ,9>>3/ rcvcdkce tldt tlc gast kostce ioaiusobcss ctlojdk
ossucs wcrc fobdbjodk prcssurcs+ projobm+ gdr`ctobm dbe djjcss+ rcscdrjl ctlojs+
mavcrbdbjc+ dbe mkaidk iusobcss"
Djjareobm ta tlc Axfare Cbmkosl Eojtoabdry+ tlc tcrg pldrgdjcutojdk ds rckdtobm ta+
ar cbmdmce ob pldrgdjy+ af tlc bdturc af d gceojobdk erum0 af ar rckdtobm ta tlc
gdbufdjturc+ usc af ar sdkc af gceojobdk erums" ,Axfare Cbmkosl Eojtoabdry+ 9>49/
Furtlcrgarc+ Vdb Cmcrddt dbe Idrry ,9>>>6+ p"34/
Frag kaa`obm dt tlcsc ecfobotoab cxdgpkcs+ ot jdb ic obfcrrce tldt tlc pldrgdjcutojdk
obeustry objkuecs pldrgdjcutojdk jagpdbocs tldt drc obvakvce ob rcscdrjl dbe
ecvckapgcbt+ tcst gceojobdk praeujts+ gdr`ctobm+ dbe eostroiutobm erums ta laspotdks
dbe pldrgdjocs" Ot eacs dppcdr tldt tlc tcrg pldrgdjcutojdk ar pldrgdjcutojdk
obeustry os vcry irade obecce dbe wokk ecpcbe progdroky ab tlc typc af pldrgdjcutojdk jagpdby dbe wldt tlcy spcjodkosc ob"
Abc af tlc jldkkcbmcs tldt pldrgdjcutojdks ldvc ta fdjc wlcb jrcdtobm obotodtovcs
tldt drc kob`ce ta Jarpardtc Zajodk Ycspabsoiokoty ,dbe sustdobdiokoty/ os tlc loml
cxpcjtdtoabs frag std`clakecrs" Ds Bussidug ,9>>?/ gcbtoabs+ pldrgdjcutojdks
drc dgabm tlc gast degorce dbe gast jrotojosce af dkk" Ulc obeustrys gdob praeujt
ds wc `baw os ta pravoec gceojdtoab tldt sdvcs kovcs+ lawcvcr+ atlcr ossucs tldt
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
3/77
>3>59?6
:
surraube tlc obeustry drc sccb ob d bcmdtovc wdy objkuec jasts+ pdtcbt ossucs+ dbe
dbogdk tcstobm far cxdgpkc"
Ulcrcfarc ldvobm JZY obotodtovcs ob arecr gust ic tlaumlt ob mrcdt ectdok ds wckk ds
ogpkcgcbtobm taaks tldt jdb lckp obtcmrdtc dbe sustdob sajodkky rcspabsoikc icldvoaur
ob d lomlky ctlojdk obeustry"
Ulc jabjcpt af Jarpardtc Zajodk Ycspabsoiokoty os lcrc ta stdy dbe sajodkky
rcspabsoiokoty eacs bat fot abc sozc fots dkk dbe jagcs ob gdby eoffc rcbt sldpcs dbe
fargs" Ulos lds obtcrcstce tlc wrotcr wla wokk eckvc eccpcr obta tlc jabjcpt af JZY
dbe law ot jdb fot d spcjofoj pldrgdjcutojdk jagpdby iy usobm d jdsc stuey
dppradjl"
4"9 Ycscdrjl Aihcjtovcs
Ulc purpasc af tlc rcscdrjl os ta kaa` dt db obeustry tldt obvakvcs d kat af ctlojdk dbe
rcspabsoikc ossucs"
Edbosl eodictcs pldrgdjcutojdk Bava Bareos` wokk ic usce ds d jdsc stuey ta
okkustrdtc eoffcrcbt gctlaes af obtcmrdtobm jarpardtc sajodk rcspabsoiokoty ob ta tlcor iusobcss gaeck"
Ulc Edbosl pldrgdjcutojdk os d mkaidk dbe wckk `bawb kcdecr ob obsukob" Frag tlc
=>s ta tlc 4??>s+ tlc jagpdby wds tdrmctce iy BMAs dbe tlc puikoj wotl rcmdres
ta praeujt qudkoty+ puikoj lcdktl+ dbe iusobcss ob Zautl Dfrojd" Bava Bareos` ecjoece
ta td`c ab db ctlojdk dppradjl wotl rcmdres ta ots iusobcss prdjtoscs" Idj` ob 9>>5
tlc jagpdby fargdkky gdec ots gdbdmcgcbt rcspabsoikc far bat abky djlocvobm
fobdbjodk tdrmcts iut ta jabjcbtrdtc ab sajodk dbe cbvorabgcbtdk ossucs+ tlcy deaptce
Halb Ck`obmtabs ,4??5/ t ropkc iattag kobc pdrdeomg ,cjabagoj ,mrawtl/+ cjakamojdk
,idkdbjc/+ dbe sajodk ,pramrcss//"
Bava Bareos` objarpardtce tlc tlrcc gdob pokkdrs af sustdobdiokoty ,cjabagoj+
cbvorabgcbtdk+ dbe sajodk/ obta tlcor jarpardtc jldrtcr+ wlojl os dkombce wotl gdby af
ots iusobcss prdjtoscs ta JZY dbe put ob pkdjc gdby jabjrctc djtoabs"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
4/77
>3>59?6
5
Frag deaptobm d garc ctlojdk wdy af tlob`obm+ Bava Bareos` lds sloftce frag icobm d
lcdvoky jrotojosce jagpdby ta db degorce dbe obbavdtovc jagpdby bat hust ob ots
bdtovc Ecbgdr` iut ab d mkaidk sjdkc" Ua djtudkky gd`c dkk tlrcc pokkdrs af
sustdobdiokoty fubjtoab wotl tlc jagpdbys edoky iusobcss prdjtoscs wds povatdk far Bava Bareos` ta icjagc d wckk `bawb JZY kcdecr ob tlc pldrgdjcutojdk obeustry"
Ulc forst aihcjtovc os ta mdob db obsomlt obta tlc batoab af JZY tlrauml tlc kcbs af
Bava Bareos`" Ulc pdpcr wokk kaa` dt tlc ecjosoab gd`obm prajcss tlc
pldrgdjcutojdk jagpdby macs tlrauml wotl rcmdres ta ots rcspabsoikc iusobcss
prdjtoscs"
Furtlcrgarc+ tlc scjabe aihcjtovc os ta ecvckap db ubecrstdbeobm af tlc jagpdbys
strdtcmoj dppradjl dbe law tlcy tdj`kc JZY rckdtce ossucs ob tlc pldrgdjcutojdk
obeustry"
4": Ycscdrjl Tucstoabs
Ot jdb ic vocwce tldt jarpardtc cbmdmcgcbt ob JZY ob tlc twcbty'forst jcbtury os
jldbmobm dbe ot ots cvoecbt tldt gdby jagpdbocs djrass Curapc drc obtcmrdtobm sagcfarg af JZY ob tlcor edoky iusobcss prdjtoscs" Jagpdbocs taedy ldvc ta ecgabstrdtc
ta tlcor std`clakecrs ds wckk ds ta d sjcptojdk dueocbjc tldt tlcy drc icobm truc ta
tlcor ware dbe icobm sajodkky dbe ctlojdkky rcspabsoikc" Ulos lds mat tlc wrotcr
tlob`obm ab law d jagpdby ko`c Bava Bareos` fdjcs tlcsc jldkkcbmcs af eaobm maae
ob d lomlky jagpctotovc dbe ctlojdk obeustry" Ulc forst qucstoab tldt tlc wrotcr wokk
cxdgobc wokk ic law eacs d wckk'`bawb pldrgdjcutojdk jagpdby sustdob d
rcspabsoikc ogdmc ob d lomlky ctlojdk obeustry1 Zcjabeky ta obvcstomdtc wldt taaksdrc bccece ta cbldbjc d sustdobdikc rcputdtoab dbe gabotar sajodkky rcspabsoikc
icldvoaur1
Ob arecr ta ubecrstdbe tlcsc qucstoabs+ tlc tcrg Jarpardtc Zajodk Ycspabsoiokoty wokk
ic taujlce upab ob mrcdtcr ectdok ob tlc kotcrdturc rcvocw dbe ob jldptcr faur tlc jdsc
stuey af Bava Bareos` wokk pravoec d mrcdtcr ubecrstdbeobm af wldt icobm rcspabsoikc
gcdbs ta tlc obsukob pldrgdjcutojdk jagpdby ds wckk ds maobm obta ectdok ab wldt
taaks dbe prajcsscs drc usce ta gabotar dbe sustdob rcspabsoikc icldvoaur"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
5/77
>3>59?6
3
4"5 Ztrujturc
Ulc gdob aihcjtovc af tlc obtraeujtoab dbe tlc gctlaeakamy ,jldptcr :/ os ta movc tlcrcdecr db obsomlt obta tlc purpasc af obquory dbe ta pravoec db ubecrstdbeobm af tlc
rcscdrjl stuey"
Ds prcvoausky gcbtoabce ob 4":+ tlc bcxt jldptcr wokk jabsost af tlc kotcrdturc rcvocw
dbe fajus ab tlc jabjcpt af Jarpardtc Zajodk Ycspabsoiokoty iy kaa`obm dt vdroaus
dutlars ecfobotoabs dbe tlcarocs"
Ulc obtcbtoab af eaobm tlos os ta ecgabstrdtc tldt JZY os d irade jabjcpt dbe tldt
cdjl jagpdby tldt deapts d JZY dppradjl slauke ecfobc ots rcspabsoikc iusobcss
prdjtoscs djjareobm ta spcjofoj strdtcmocs ds wckk ds jagpdby dgiotoabs"
Furtlcrgarc+ tlc kotcrdturc rcvocw dogs ta slaw tldt obtcmrdtobm JZY os ba abc sozc
fots dkk strdtcmy"
Ob jldptcr :+ tlc gctlaeakamy af tlc tlcsos wokk ic eosjussce dbe wokk kaa` dt tlc
jlascb gctlaeakamojdk prajcsscs tldt ldvc iccb deaptce far tlos rcscdrjl pdpcr"
Db obtcrprctovost pdrdeomg lds iccb usce ds wckk ds vocwobm tlc warke frag db
abtakamojdk pcrspcjtovc dkabm wotl atlcr rcscdrjl tcjlboqucs gcbtoabce ob tlc
jldptcr+ pkus kaa`obm dt wly tlcsc rcscdrjl gctlaes ldvc iccb usce far tlos stuey"
Ulc faurtl pdrt af tlc tlcsos wokk ic tlc jdsc stuey ab Bava Bareos` wlojl wokk
objkuec d irocf avcrvocw ab tlc jagpdbys lostary ds wckk cxpkarobm tlcor rcdsabs far
obtcmrdtobm Jarpardtc Zajodk Ycspabsoiokoty obta tlcor iusobcss strdtcmy" Ulos jldptcr
wokk dksa objkuec gaecks ab tlc vdroaus taaks tldt drc usce ta sustdob rcspabsoikc
iusobcss icldvoaur frag usobm Halb Ck`obmtabs Uropkc Iattag Kobc dppradjl ta
Bava Bareos`s vcry awb taak+ Ulc Bava Bareos` ]dy af Gdbdmcgcbt" Ulc obtcbt oab
af tlc eosjussoab os ta kaa` dt tlc ecjosoab gd`obm prajcss wlcb ogpkcgcbtobm JZY
rcmukdtoabs dbe prdjtoscs ds wckk ds kaa`obm dt tlcsc vdroaus taaks dbe sccobm law
cffojocbt tlcy drc dbe law tlcy gabotar dbe sustdob sajodk rcspabsoikc icldvoaur"
Ulc tlcsos wokk ic jagpkctce iy dsscssobm tlc rcscdrjl fobeobms dbe tlcb jabjkueobmtlc gdob fobeobms ob tlc jabjkusoab"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
6/77
>3>59?6
6
Jldptcr 9' Kotcrdturc Ycvocw
9"> Kotcrdturc Ycvocw
Ecfobobm tlc jabjcpt af JZY os bat ds sogpkc ds ot gdy sccg" Vatdw ,4?=:/ abjcstdtce tldt Jarpardtc Zajodk Ycspabsoiokoty gcdbs sagctlobm+ iut bat dkwdys tlc
sdgc tlobm ta cvcryiaey" ,Vatdw+ 4?=:+ p"93/ Cvcb taedy pcapkc drc stokk jabfusce
iy tlc luberces af ecfobotoabs tldt ldvc iccb jrcdtce iy djdecgoj sjlakdrs" Ulc
jabjcpt af JZY+ sagctogcs+ os gdbopukdtce wotl cdsc ta fot ob wotl abc prc'
jabjcovce batoab ar atlcr tldt wokk pkcdsc tlc jldorgdb ar tlc jagpdbocs
sldrclakecrs" ,Lap`obs+ 9>>6+ jotce iy Xu+ 9>>?+ p"4>?+
p"4s wlojl gdr`s tlc iortl af gaecrb edy JZY"
Ecfobotoabs mrcw avcr tlc 4?6>s dbe 4?=>s+ far cxdgpkc Frocegdb ,4?=>/+ stdtce
tldt tlc abky iusobcss af iusobcss os iusobcss + gcdbobm tldt iusobcss lds ba atlcr
rcspabsoikc purpasc atlcr tldb icobm cjabagojdk"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
7/77
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
8/77
>3>59?6
4>+ p"=6/ Jdgpickk ,9>>=/ drmucs tldt gujl af tlc kotcrdturc ab jarpardtc
sajodk rcspabsoiokoty lds iccb ta sagc cxtcbt+ taa ecsjroptovc dbe slauke progdroky
fajus ab cxtcrbdk gcjldbosgs tldt obfkucbjc wlctlcr jarpardtoabs icldvc ob d
sajodkky rcspabsoikc gdbbcr ar bat+ dbe ta of tlcy drc obfkucbjce iy tlc prcssurc af
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
9/77
>3>59?6
?
strabm dbe wckk rcmukdtce stdtc rcmukdtoabs pkus tlc prcssurc af d systcg af wckk
armdbosce dbe cffcjtovc obeustrodk sckf'rcmukdtoab" ,Jdgpickk+ 9>>=/
Zloftobm ta tlc scjabe pcrspcjtovc+ tlc scbscgd`obm dppradjl dksa lds tlc sdgc
jrotoquc af tlc obstotutoabdk dppradjl wotl rcmdres ta jarpardtc sajodk rcspabsoiokoty+ ot
lds iccb vocwce tldt JZY lds iccb dppradjlce frag d rdtoabdk pcrspcjtovc dbe taa
gujl dttcbtoab lds iccb jcbtrce ab tlc batoab af JZY djtovotocs"
Zcbscgd`obm lds iccb ecsjroice ds d prajcss iy wlojl obeovoeudks ecvckap
jambotovc gdps af tlcor cbvorabgcbt" ,Yobm & Ydbes+ 4?
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
10/77
>3>59?6
4>
tlc jaggab maae+ dkabm wotl tlcor icldvoaurdk eospasotoab wotl rcspcjt ta tlc
fukfokgcbt dbe djlocvcgcbt af tlcsc" ,Idsu dbe ^dkdzza+ 9>>>6+
jotce iy Garsobm dbe Kcbsscb+ 9>>6+ p"953/ Ob deeotoab+ tlc twa dutlars batc tldt iy
cbmdmobm wotl std`clakecrs rcquorcs eodkamuc frag obtcrbdk dbe cxtcrbdk
std`clakecrs dbe eodkamuc os votdk far tlc fubjtoab af frcc sajocty dbe jdpotdkosg" Ulos
kcdes ta ldvobm d iusobcss iuokt ab labcsty dbe apcbbcss iy gdbdmobm std`clakecr rckdtoabslops obtcrbdkky dbe cxtcrbdkky dbe cbmdmobm ob eodkamuc wotl tlcsc vdroaus
mraups icjagcs db csscbtodk fdjtar wotl rcmdres ta jarpardtc sajodk rcspabsoiokoty"
Vdkuc jrcdtoab dbe std`clakecr rckdtoabslop gdbdmcgcbt dppcdrs ta ic cvoecbt ob
Jdrrakks ,9>>:/ dbe Ck`obmtabs ,9>>4/ rcscdrjl" Far cxdgpkc+ Jdrrakk gcbtoabs tldt
tlc pyrdgoe af JZY rcprcscbts d std`clakecr pcrspcjtovc dbe cdjl faur af tlc
jagpabcbts ob tlc pyrdgoe af JZY ,cjabagoj rcspabsoiokotocs+ kcmdk rcspabsoiokotocs+
ctlojdk rcspabsoiokotocs+ dbe plokdbtlrapoj rcspabsoiokotocs/ deercsscs eoffcrcbt
std`clakecrs" ,Jdrrakk dbe Iujllaktz+ 9>>:+ p"54/
Garcavcr+ Ck`obmtab dbe wlcckcr ,9>>4/ dksa drmucs wotl d gukto std`clakecr
dppradjl dbe quatcs tldt ot os icjagobm jkcdr tldt jaggubojdtobm cffcjtovcky wotl
std`clakecrs ab pramrcss tawdres cjabagoj praspcroty+ cbvorabgcbtdk qudkoty dbe
sajodk obhustojc o"c" tlc tropkc iattag kobc+ wokk icjagc d ecfobobm jldrdjtcrostoj af
jarpardtc sajodk rcspabsoiokoty ob tlc 94 st jcbtury" ,Ck`obmtab dbe ]lcckcr+ 9>>4+
p"4/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
11/77
>3>59?6
44
Ulauml Ck`obmtab dbe wlcckcr dmrcc wotl d std`clakecr dppradjl ta JZY iy usobm
std`clakecr jaggubojdtoab dbe jabsuktdtoab ds csscbtodk taaks+ ot sccgs tldt lc
prcfcrs abc'wdy jaggubojdtoab" Zjlakdrs sujl ds Frccgdb lawcvcr+ cgpldsosc
tlc bcce far d twa'wdy jaggubojdtoab prajcss wotl tlc deeotoab af std`clakecr eodkamuc"
Habcs ,9>>3/ vocws tldt tlc cxjldbmc ictwccb jagpdbocs dbe tlcor std`clakecr
mraups os dkwdys twa' wdy" Mrubobm ,4??>/ prapascs d twa ' wdy syggctrojdk gaeck
tldt obvakvcs eodkamuc ictwccb d jagpdby dbe tlc mcbcrdk puikoj ob arecr ta djlocvc
d gutudk ubecrstdbeobm+ wlojl gavcs puikoj rckdtoabs dwdy frag icobm pcrjcovce ds
gdbopukdtovc ta trdbsfargobm dbe td`obm ab iadre guktopkc dttotuecs frag iatl obtcrcst
af tlc jagpdby dbe std`clakecr mraups" Jlrostcbscb dbe Habcs ,4??6/ gcbtoab tldttwa wdy syggctrojdk jaggubojdt oab prdjtoscs drc garcavcr drmuce ta icjagc
objrcdsobmky woecsprcde ds std`clakecrs icjagc garc jrotojdk dbe djtovc ob tcrgs af
JZY" ,Jlrostcbscb dbe Habcs+ 4??6+ p"43>6/ vocw tlrcc typcs af std`clakecr
rckdtoabs wotl rcmdres ta std`clakecr rckdtoabs dbe kdw jagpdbocs cbmdmc wotl JZY
jaggubojdtoab" Ulcy gcbtoab tlc tlrcc JZY jaggubojdtoab strdtcmocs ds8 tlc
std`clakecr obfargdtoab strdtcmy+ tlc std`clakecr rcspabsc strdtcmy dbe+ tlcstd`clakecr obvakvcgcbt strdtcmy" Furtlcrgarc+ tlcy drmuc tldt abc'wdy
jaggubojdtoab ,fdvaurce iy Ck`obmtab dbe ]lcckcr/ dbe twa'wdy jaggubojdtoab
fdvaurce iy Frccgdb/ drc iatl ogpartdbt+ lawcvcr+ tlcrc os db objrcdsc ta ecvckap d
twa'wdy jaggubojdtoab pra jcss wlcb ot jagcs ta ecvckapobm JZY eodkamuc" ]lokc
abc'wdy obfargdtoab af JZY obotodtovcs os bcjcssdry+ ot os bat cbauml far d
jarpardtoab ta iuoke dbe gdobtdob kcmotogdjy" ,Garsobm dbe Zjluktz+ 9>>6+ p"45>/
Ob `d`idesc ct dk"+ ,9>>3/ rcscdrjl ab Jarpardtc sajodk rcspabsoiokoty dbe
std`clakecr dppradjl8 d jabjcptudk rcvocw + tlcy rcjaggcbe tldt jagpdbocs slauke
ic pkdjce ab jabstrujtovc dbe apcb eodkamuc wotl tlc dog af jagiobobm slart'tcrg
pcrfargdbjc wotl kabm tcrg armdbosdtoabdk wcdktl" Db csscbtodk ckcgcbt tldt rckdtcs
ta std`clakecr gdbdmcgcbt os tlcrcfarc eodkamuc ictwccb tlc jagpdby dbe ots
std`clakecr mraups ob arecr ta jrcdtc sldrce vdkuc"
Luggcks ,4??
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
12/77
>3>59?6
49
wlojl kcdes ta eoffcrcbt ,cxpcjtce/ eostroiutoabs af icbcfots dbe iurecbs+ af pkcdsurcs
dbe pdobs+ af vdkucs+ romlts dbe obtcrcsts dgabmst obtcrprctdtoabs" ,Luggcks+4??
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
13/77
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
14/77
>3>59?6
45
lds iccb lcke ta farg tlc frdgcwar` af JZY prdjtoscs ob Bomcrodb sajocty" Dksa+ tlc
strabm rckomoaus obfkucbjc ab jagpdby prdjtoscs wotl rcmdres ta JZY lds dksa iccb
taujlce upab" Cgiceece ob JZY prdjtoscs ob Bomcrod os tlc rckomoaus batoab af moft
dbe sdjrofojc+ dppdrcbtky+ iraumlt ta kogckomlt iy tlc twa eagobdbt rckomoabs' Oskdgdbe Jlrostodboty" Srop ,9>4>/ quatcs tldt sa far tlc kcss cjabagojdkky ecvckapce
bdtoabs+ ot os ogpartdbt tldt JZY djtovotocs put sagc fajus ab tlc djtoabs af
sustdobdikc wcdktl far tlc jagguboty+ pdrtojukdrky far tlc kawcr' objagc sajocty"
,Srop+ 9>4>+ p"46/
Frag obfcrrobm frag Srop ,9>4>/+ tlos jdb ic eabc iy cstdikoslobm tlc ko`cs af
jagguboty ceujdtoab sjlcgcs+ lcdktl devojc+ maae jarpardtc mavcrbdbjc+ dbe
qudkoty dssurdbjc" Cffcjtovc ogpkcgcbtdtoab af JZY ob ecvckapobm jaubtrocs tldtldvc wcd` kdw cbfarjcgcbts+ ajjdsoabdk fobdbjodk dbe pakotojdk obstdiokoty+ pavcrty+
dbe d kaw ceujdtoabdk kcvck+ rcquorcs dksa tlc gdjlobcry af db cffcjtovc ecgajrdtoj
mavcrbgcbt dbe jovok sajocty" ,Srop 9>4>+p"4?/
Ob tlc ecvckapobm warke+ ot jdb ic vocwce tldt JZY os bat d taak far sakvobm pavcrty
dbe d kdj` af war` appartubotocs dbe jarruptoab far cxdgpkc0 lawcvcr+ ot jdb ic
vocwce ds db csscbtodk obstrugcbt far jagpdbocs ta deapt dbe lckp mavcrbgcbts
suppart kajdk jaggubotocs dbe kajdk strujturcs"
9"5"9 Zjdbeobdvod
Zobjc tlos pdpcr os idsce ab d Zjdbeobdvodb jagpdby+ tlc trdeotoab af sajodk
rcspabsoiokoty ob Ecbgdr` far obstdbjc+ sajodk rcspabsoiokoty dbe ecgajrdjy ma ldbe
ob ldbe+ tlc gdhar ecvckapgcbts stdrtce ob tlc kdtcr stdmcs af tlc twcbtoctl jcbturytlcsc tocs drc jabbcjtce wotl tlc cgcrmcbjc af tlc wckfdrc stdtc pkus ldvobm strabm
sajodk ecgajrdtoj obfkucbjcs"
Ot jdb vocwce tldt Bareoj iusobcss systcgs drc dt aees wotl tlc iusobcss sajocty
gaeck af rcspabsoikc iusobcss+ tlos os icjdusc ds Mhkicrm ,9>4>/ puts ot+ tldt JZY
ogpkojotky mrdbts eosjrctoabdry pawcrs ta iusobcss ob ossucs af mrcdt sajodk dbe
cbvorabgcbtdk jabjcrb+ wlokc ob d Bareoj jabtcxt sujl ossucs drc jabsoecrce ta
ickabm tlc puikoj eagdob+ ta ic ecjoece tlrauml ecgajrdtoj+ jakkcjtovc+ ar
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
15/77
>3>59?6
43
rcprcs cbtdtovc prajcsscs" , Mhkicrm+ 9>4>+ p"944/ Zjdbeobdvodb mavcrbgcbts dkk
ldvc strabm obtcrbdtoabdk prafokcs wlcb ot jagcs ta ossucs ab sustdobdikc
ecvckapgcbt+ pavcrty+ lugdb romlts+ dbe cbvorabgcbtdk pratcjtoab" Frag kaa`obm dt
tlcsc prcvoausky gcbtoabce ossucs+ tlcsc ossucs drc tlcrcfarc drc dkk strabmky kob`cewotl tlc jabjcpt af JZY"
Mhkicrm ,9>4>/ gcbtoabs ob lcr pdpcr Vdroctocs af Jarpardtc Zajodk Ycspabsoiokoty
,JZY/8 JZY gccts tlc Bareoj Gaeck tldt tlcrc os d jkcdr kob` wotl scvcrdk ckcgcbts
af JZY tldt drc pdrtojukdrky objagpdtoikc wotl fubedgcbtdk vdkucs dbe pakotojdk'
cjabagoj obstotutoabs ob Zjdbeobdvod" Frag obfcrrobm frag Mhkicrm ,9>4>/+ tlos
sotudtoab wlcrc sagc JZY ossucs drc objagpdtoikc+ Bareoj puikoj pakojocs ab
Jarpardtc Zajodk Ycspabsoiokoty wokk rcfkcjt tlc aromobdk JZY prdjtoscs!gaeck+lawcvcr+ tlcsc pakojocs wokk ic dktcrce ta fot wotl tlc Bareoj Gaeck" Garcavcr+ ot os
garc dppdrcbt tldt obtcmrdtobm dbe trdbsfargobm JZY wokk ic sagcwldt sogokdr
djrass cdjl af tlc Bareoj bdtoabs+ euc ta tlc fdjt tldt tlcrc drc d kat af sogokdrotocs ab
tlcor vocws ab iusobcss ob sajocty"
Atlcr tlcarosts drmuc tldt icjdusc Zjdbeobdvodb jaubtrocs gox sajodk wckfdrc wotl
cjabagoj jagpctovcbcss+ tlcrc os wldt sagc ldvc euiice Bareoj jdpotdkosg" Ot
sccgs frag d Zjdbeobdvodb paobt af vocw tldt JZY os scjabe icst ds d strdtcmy tldt
ob atlcr pdrts af tlc warke os sccb ds d progdry ossuc" Ulos os aivoausky euc ta ldvobm
d vcry strabm wckfdrc systcg ob pkdjc ds wckk ds ldvobm d strabm scbsc af
mavcrbgcbt pdrtojopdtoab ab ossucs idsce ab jagguboty jabjcrbs"
Ior`ob ct dk"+ ,9>>?/ rcscdrjl ab D Bcw Iusobcss Gaeck far Zustdobdikc
Ecvckapgcbt gcbtoab ob tlcor pdpcr tldt Bareoj jaubtrocs lde djquorce sajodkky
rcspabsoikc dbe sustdobdikc icldvoaurs+ wlojl lds iccb erdwb ta dttcbtoab ta tlccxtcbt ta wlojl tlcor sajocty cxloiotce sldrce sajodk vdkucs" Ob pdrtojukdr+ tlcy batce
tldt ogpartdbjc wds dttdjlce ta ,4/ sajodk cquoty wotlob d jabscbsus sajocty dbe ,9/
d kavc af bdturc+ dbe tlc ecmrcc ta wlojl af tlcsc wcrc cgiceece ob tlc jukturc af
sajocty" ,Ior`ob ct dk"+ 9>>?+ p"9
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
16/77
>3>59?6
46
dbtojopdtcs icbcfots sujl ds icttcr qudkoty cgpkayccs+ garc mcbcrdk jaapcrdtoab+
cdsocr dvdokdiokoty af kojcbscs dbe garc kodikc jabsugcr suppart" ,Ior`o b ct dk"+ 9>>?+
p"9s kdubjlce gdby objcbtovc sjlcgcs ta cbjaurdmc jagpdbocs ta cgpkay tlc
ko`cs af oggomrdbts+ kabm'tcrg ubcgpkayce pcapkc+ dbe tlc ldbeojdppce" Iy tlc bcw
gokkcbboug+ d erdgdtoj jldbmc ob JZY pakojy taa` pkdjc ds d rcsukt af iattag'up dbe
d tap eawb prajcss tldt spurrce tlc jaubtrys cbjaubtcr wotl mkaidkosdtoab" Mhkicrm
,9>4>/ gcbtoabs tldt tlrauml tlos iattag u p suppky jldob eybdgoj+ d mrdeudk sloft ob
tlc jabjcptudkosdtoab af JZY taa` pkdjc ob tlc Edbosl eosjaursc frag tlc bdrraw+eagcstoj dmcbed ab objkusovc war`'kofc ossucs tawdres d eosjaursc ob kobc wotl tlc
obtcrbdtoabdk tropkc iattag'kobc dppradjl ta JZY" ,Mhkicrm+ 9>4>+ p"944/
Furtlcrgarc+ tlos tap'eawb pakotojdk prajcss wlojl ubjavcrce db cxpkdbdtoab mdp
wlojl idffkce tlc Edbosl dutlarotocs ab wly Ecbgdr` `cpt ab tappobm
jagpctovcbcss dbe mrawtl warke rdb`obms" Mavcrbgcbt obtcrvocwccs frag
Mhkicrms ,9 >4>/ rcscdrjl gcbtoab tldt tlos batoab wds kob`ce ta wldt tlcy jaobce
tlc Edbosl Gaeck" Lcbjc+ d bcw jabjcptoab af JZY wds iarb+ wlojl rckdtce ta tlc
eosjaursc af jagpctovcbcss+ cjabagoj mrawtl+ dbe mkaidkosdtoab"
Ot sccgs tldt Edbosl sajocty pravoecs sagc jukturdk trdots tldt jdb erovc tlc jabjcpt
af JZY farwdre+ Ldiosjl ct dk"+ ,9>>5/ gcbtoab tldt Edbosl sajocty jdb erovc tlos
prajcss farwdre iy ldvobm d mcbcrdk jagpctcbjc far eodkamuc dbe bcmatodtoab+ d
wokkobmbcss ta cbmdmc dbe d irade scbsc af trust drc jukturdk trdots saumlt far ob tlc
qucst far objrcdsobmky scbsotovoty tawdres d vdrocty af std`c lakecrs" ,Ldiosjl ct dk"+,9>>5/ p":9/
Ot jdb ic sdoe tldt ot td`cs ecgajrdtoj eosjopkobc dbe jaggubojdtoab s`okks ta jrcdtc d
rcdsabdikc dbe sdtosfdjtary idkdbjc ictwccb eovcrsc obtcrcsts" Ldiosjl ct dk"+
,9>>5 / quatc tldt of Jarpardtc Zajodk Ycspabsoiokoty os diaut objrcdsobm scbsotovoty
tawdres std`clakecrs+ Edbosl gdbdmcrs sccg ta ldvc d maae paobt af ecpdrturc"
Ulos jcrtdobty eacs bat gcdb tldt tlcrc drc ba jldkkcbmcs dlcde wotl rcmdres ta
Edbosl JZY" Ko`c ob gdby atlcr Jaubtrocs+ JZY os d gavobm tdrmct" Far cxdgpkc+
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
17/77
>3>59?6
4=
wldt wds pcrjcovce ds rcspabsoikc icldvoaur fovc ycdrs dma gdy bat ic djjcptce ob
taedys cvcr jldbmobm iusobcss jkogdtc"
9"3 Abc sozc eacs bat fot dkk
Ulraumlaut tlos kotcrdturc rcvocw+ tlc wrotcr lds kaa`ce dt d vdst dgaubt af
ecfobotoabs frag cdrky jabjcpts ta kaa`obm dt d garc af d scbscgd`obm dppradjl af
tlc jabjcpt" Ot os jkcdr tldt tlcrc drc gdby uscfuk dbe obsomltfuk ecfobotoabs tldt gdby
sjlakdrs dbe djdecgojs ldvc javcrce+ lawcvcr+ tlcrc os bat'dbe gast ko`cky jdbbat
ic d prcjosc ecfobotoab af JZY+ euc ta tlc fdjt tldt tlc ecfobotoab dbe prdjtoscs af tlc
jabjcpt wokk eoffcr frag abc jaubtry ta dbatlcr+ dbe wokk cvakvc avcr d pcroae af togc+pkus wokk dksa eoffcr dgabm jagpdbocs" Abc dmrcce sogpkofoce ecfobotoab tldt tlc
wrotcr lds faube os tldt JZY os tlc rcsukt+ ogpkojot ar cxpkojot+ af d forg+ ots rakc ob
sajocty dbe ots rckdtoabslop wotl ots obtcrbdk dbe cxtcrbdk std` clakecrs" , Drmdbead
dbe Laovo`+ 9>>?+ p"49/
Ulos vocw rcfkcjts tlc tds`s af awbcrs dbe gdbdmcrs+ iut dksa std`clakecrs wla
ldvc d eovoece ogpdjt ab tlc jagpdby" Ulc autjagc wokk vdry frag iusobcss ta
iusobcss dbe wokk ic kob`ce wotl lostarojdk cvcbts+ m camrdply+ kcmoskdtoab+ sajoctys
cxpcjtdtoabs+ ds wckk ds jurrcbt trcbes sujl ds mkaidk cjabagoj dbe fobdbjodk
prcssurcs" Uamctlcr+ tlos fargs tlc frdgcwar` ob wlojl d jagpdby apcrdtcs dbe
ecfobcs law d jagpdby jdb ecvckap dbe mraw ots JZY djtovotocs"
Icjdusc tlc iusobcss warke os dkwdys rdpoeky jldbmobm+ ot os tlcrcfarc bat passoikc ta
dmrcc ab db affojodk ar ubovcrsdk dmrccgcbt ab tlc jabjcpt icjdusc fdjts dbe oecds+
sajocty+ plokasaply+ dbe tlc cbvorabgcbt drc dkk obtcrjabbcjtce" Ds prcvoauskygcbtoab tlc jabjcpt lds jldbmce avcr togc dbe wokk jabtobuc ta ea sa ob tlc futurc"
Iy stueyobm dbe rcscdrjlobm gdby oecds dbe ecfobotoabs far tlc purpasc af tlos
kotcrdturc rcvocw+ wlcb JZY os ecfobce+ tlc jabjcpt gust ic ira`cb eawb dbe
stueoce iy ogpkojotky ecfobobm tlc wlakc sct af obtcrrckdtce rcspabsoiokotocs dbe rakcs ob
sajocty" Ob deeotoab+ JZY os bat sogpky d iusobcss ctlojs suihcjt+ iut dksa kob`ce wotl
pakotojdk ctlojs dbe sajodk ctlojs tldt gust ic dksa td`cb obta jabsoecrdtoab" Ulos os
icjdusc tlc obtcrpkdy ictwccb iatl stdtc dbe provdtc djtars os jldbmobm dbe
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
18/77
>3>59?6
49/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
19/77
>3>59?6
4?
Dktlauml lc batcs tldt tlos ecfobotoab jdb ic pcrjcovce ds icobm sagcwldt vdmuc
dbe quotc irade+ tlc wrotcr dmrccs wotl tlos ecfobotoab ds std`clakecr obtcrdjtoab os d
votdk pdrt af tlc JZY dmcbed" Ob deeotoab+ Jdrakk ,4??4/ gcbtoabs tldt JZY
rcprcscbts sajoctdk cxpcjtdtoabs af jarpardtc icldvoaur0 d icldvoaur tldt os dkkcmceiy d std`clakecr ta ic cxpcjtce iy sajocty ar gardkky rcquorce dbe os tlcrcfarc
hustofodiky ecgdbece iy sajocty" ,Jdrakk+ 4??4+ jotce iy Zgotl ct dk"+ 9>4>+ p"46:/
Ot jdb ic jabjkuece tldt frag kaa`obm dt tlos kotcrdturc rcvocw tldt JZY ds d jabjcpt
os vcry jagpkojdtce dbe irade" Ulc wrotcr strcsscs tldt tlc djjcptdbjc af pravoeobm d
ubovcrsdk ecfobotoab af JZY os bat passoikc dbe tlcrcfarc jagpdbocs gust ecjoec ab
law tlcy wdbt ta objarpardtc dbe ecfobc JZY wlojl kob`s eorcjtky ta tlcor obeustry+
s`okks+ dbe cxpcrtosc" Bat abky wokk jagpdbocs ldvc ta ecjoec wldt JZY gcdbs tatlcg+ tlcy wokk ldvc ta dksa fdjc cvcryedy jldkkcbmcs af icobm sajodkky rcspabsoikc
dbe ic dikc ta wdk` dbe tdk` JZY cffcjtovcky" Ulos os sagctlobm tldt wokk ic slawb ob
jldptcr 5 af tlos rcscdrjl pdpcr"
Jldptcr : Ycscdrjl Ecsomb
:"4 Ycscdrjl ^lokasaply
Ulc rcscdrjl plokasaply tldt wokk ic usce wokk ic db obtcrprctovc pdrdeomg icjdusc
tlc rcscdrjl os rcfkcjtce iy atlcr dutlars dssugptoabs dbe ob deeotoab wokk ic garc
jldrdjtcrosce iy d garc suihcjtovost stdbjc tawdres tlc bdturc af sjocbjc"
Ulc abtakamojdk dssugptoab ob tlos pdpcr wokk td`c d bagobdkost vocwpaobt+ wlojl
obtcrprcts tlc sajodk warke ob db cxtcrbdk jabtcxt tldt os gdec up af jabjcpts+ bdgcs+
dbe kdicks tldt drc usce ta strujturc rcdkoty dbe gd`c scbsc af tlc cxtcrbdk warke"
Ulc cxtcrbdk warke os tlcrcfarc bat dssugce ta jabsost af ldre dbe tdbmoikc
strujturcs dbe cxost obecpcbecbtky af obeovoeudks" ,Iurrckk ct dk"+ 4?=?+ p"5/
Ulc tcrg abtakamy jagcs frag tlc Mrcc` wares abtas gcdbobm icobm dbe kamas
gcdbobm tlcary" Icobm os tlc cxtcb ece tcrg wotl tlc jabjcpt af cxostcbjc
suisugce ubecr ot" ,Jabbdwdy dbe ^awckk+ 9>4>+ p"9?/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
20/77
>3>59?6
9>
D suihcjtovc ubecrstdbeobm lds iccb deaptce far tlos rcscdrjl pdpcr0 tlos os
icjdusc suihcjtovosg vocws tlc jukturc af db armdbosdtoab ds d rcsuktobm prajcss af d
jabtobuobm sajodk cbdjtgcbt"
Furtlcrgarc+ suihcjtovosts wauke drmuc tldt jukturc os sagctlobm tldt os jrcdtce
tlrauml jagpkcx plcbagcbd tldt objkuecs sajodk obtcrdjtoabs dbe plysojdk fdjtars"
Zdubecrs ct dk"+ ,9>>?/ gcbtoab tldt ot os tlc gcdbobms tldt drc dttrdjtce ta tlcsc
plcbagcbd iy sajodk djtars wotlob tlc armdbosdtoab tldt bcce ta ic ubecrstaae ob
arecr far jukturc ta ic ubecrstaae" ,Zdubecrs+ G" ct dk"+ 9>>?+ p"444/
Ulc tlore ckcgcbt af tlc rcscdrjl plokasaply far tlos pdpcr os ta dksa td`c d
jabstrujtovost pcrspcjtovc" Ulos pcrspcjtovc drmucs tldt djtars jabstrujt tlcor awb
rcdkoty dbe tlcy gd`c scbsc af wldt atlcrs eospkdy ta tlcg" Frag d jabstrujtovost
pcrspcjtovc+ plcbagcbd ko`c JZY jdb ic ecfobce ds sajodk jabstrujts tldt drc fokkce
wotl eoffcrcbt gcdbobms ,Olkcb ct dk"+ 9>44+ p"5=:/+ tlcsc gcdbobms drc tlcrcfarc
obstotutoabdkosce tlrauml vdroaus fargs af prajcsscs tldt drc tlcb obtcrprctce iy
gdby eovcrsc djtars sujl ds jarpardtoabs+ tlc stdtc+ BMAs+ ctj"
D kcss rdeojdk vocwpaobt ab rcdkoty lds iccb ogpkcgcbtce ob tlos pdpcr ds ot os
tlcrcfarc pcrjcovce tldt tlcrc os d warke iatl ob d plysojdk dbe sajodk farg jdb icsccb frag gdby eoffcrcbt paobts af vocw" Ulcsc dssugptoabs tldt drc jrcdtce
icjdusc ot os drmuce tldt jagpdbocs dbe tlc batoab af Jarpardtc Zajodk
Ycspabsoiokoty drc sajodk jabstrujtoabs tldt kovc dbe ircdtlc ob tlc sajodk warke iut ea
bat cxost ob tlc plysojdk warke0 tlcrcfarc tlc sajodk warke wokk ic d gdhar obfkucbjc
wotl rcmdres ta tlos tlcsos"
Ulos pdrtojukdr rcscdrjl pdrdeomg wokk tlcrcfarc kcde tlc wrotcr ta eosjuss dbe
jabjkuec wly Bava Bareos` lcdvoky ogpkcgcbts JZY obta ots strdtcmy+ scjabeky law
tlc jagpdby gdbdmcs tlc jabjcpt af JZY+ dbe tloreky taujlobm upab futurc
rcscdrjl dbe rcjaggcbedtoabs"
:"9 Tudkotdtovc dppradjl
Tudkotdtovc rcscdrjl os oecdk icjdusc ot eckvcs obta tlc bdturc af pcapkcs vocwpaobts
dbe pcrspcjtovcs" Cxdgobobm tlc wdy Bava Bareos` obtcmrdtcs ots rcspabsoikc
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
21/77
>3>59?6
94
iusobcss prdjtoscs usobm d jdsc stuey gctlaeakamy movcs tlc wrotcr d eccpcr obsomlt
ab tlc pldrgdjcutojdk jagpdbys wdy af jldgpoabobm JZY prdjtoscs"
Ds Idiioc ,9>4>/ gcbtoabs+ tlc qudkotdtovc rcscdrjlcr wokk aftcb dbdkyzc dbe rcpart
edtd jakkcjtce frag spcjofoj+ oecbtofodikc obeovoeudks" ,Idiioc+ 9>4>+ p"544>+ p"54>3+ jotce iy
Idugmdrtcb+ 9>49+ p"4:/
Ycscdrjlcrs sujl ds Garsobm dbe Aswdke ,9>>3/ ,9>>?/ dbe Lapwaae ct dk"+ ,9>4>/
,wla ldvc jabeujtce rcscdrjl dbe jdsc stueocs ab Bava Bareos`/ wauke ldvc usce
tlos dppradjl wlcb edtd jakkcjtobm+ iy ds`obm tlc rcspabecbts of tlcy lde sogokdr vocws rckdtce ta tlcor rcscdrjl ab Bava Bareos`s rcspabsoikc iusobcs s prdjtoscs"
Coscbldret dbe Mrdcibcr ,9>>=/ strcss tldt tlc diokoty af usobm qudkotdtovc edtd movcs
db obsomlt obta jagpkcx sajodk prajcsscs+ tlcrcfarc tlos typc af edtd wokk movc tlc
wrotcr d icttcr ubecrstdbeobm dbe cxpkarc tlc jabjcpt af Jarpardtc Zajodk
Ycspabsoiokoty dbe law pldrgdjcutojdk jagpdbocs sujl ds Bava Bareos` cgice tlos
strdtcmy ob tlcor cvcryedy iusobcss prdjtoscs"
:": Jdsc stuey dppradjl
Ulc wrotcr obtcbes ab usobm d jdsc stuey dppradjl frag dutlars wla ldvc dkrcdey
jakkcjtce qudkotdtovc edtd ab tlc jagpdby" Ulc purpasc af usobm d jdsc stuey os far
obvcstomdtobm armdbozdtoabdk strujturc dbe fubjtoabs ar armdbozdtoabdk pcrfargdbjc"
Gast rcscdrjlcrs jabsoecr tlc jdsc stuey ta ic rckdtovcky kaw ob obtcrbdk dbe cxtcrbdk
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
22/77
>3>59?6
99
vdkoeoty+ iut ot jcrtdobky lds tlc patcbtodk ta ic d vdkudikc rcscdrjl taak" ,Jabbdwdy
dbe ^awckk 9>4>+ p"/
Furtlcrgarc+ usobm d jdsc stuey ds d rcscdrjl taak os ogpartdbt icjdusc ot slaws
tlc iommcr pojturc" Ot jdb dksa jabbcjt cvcbts wotl tlcor cbvorabgcbt ob db obtcmrdtce
gdbbcr tldt stdrts wotl tlc rcscdrjl qucstoab dbe cbes wotl fobeobms dbe d
jabjkusoab",Gdbeo+ 9>>>=/" Djjareobm ta _ob ,4??5/ jdsc
stuey rcscdrjl os prcfcrdikc ob tlos jabtcxt+ sobjc ot dkkaws tlc obvcstomdtoab ta rctdob
tlc lakostoj dbe ogpartdbt uboqucbcss af edoky cvcbts ,_ob+ 4??5/"
Ulc usc af jagiobobm vdroaus jdsc stueocs tamctlcr os icjdusc tlc rcsukts af
guktopkc jdsc stueocs drc jabsoecrce ta ic garc pcrsudsovc+ dbe avcrdkk tlc
obvcstomdtoab wokk ic garc raiust ,_ob+ 4??5/"
Ob atlcr wares+ d gctd'dbdkysos lds iccb deaptce+ wlcb dbdkysts icmob d gctd'
dbdkysos+ tlcy gust oecbtofy tlc jdscs tldt tlcy wdbt ta stuey ,Ydmob dbe Icj`cr+
4??9+ jotce iy Yueck+ 9>>>=+ p"=9/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
23/77
>3>59?6
9:
Ob jabtrdst+ tlcrc ldvc iccb jrotojosgs af usobm scjabedry edtd+ far cxdgpkc+ tlc
djjurdjy af tlc edtd td`cs scvcrdk tlobms obta jabsoecrdtoab" Forstky+ tlcrc os tlc
qucstoab af wlctlcr tlc scjabedry edtd tldt lds iccb faube jdgc frag d progdry ar
scjabedry saurjc"
Ulc bcxt paobt ta kaa` dt os tlc armdbozdtoab tldt aromobdkky taa` pdrt ob tlc edtd
jakkcjtoab" Ulos kcdes ta tlc qucstoab af wldt os tlc qudkoty af tlcor edtd mdtlcrobm
ecsomb1 Dbe wldt os tlc `bawb jrceotdiokoty af tlcor edtd jakkcjtoab1 Ulc dmc af tlc
edtd os dksa votdk+ ]rcb ct dk"+ ,9>>=/ quatc tldt ake obfargdtoab os bat bcjcssdroky
ide obfargdtoab0 lawcvcr+ ob gdby eybdgoj gdr`cts+ up'ta'edtc obfargdtoab os db
disakutc bcjcssoty" ,]rcb ct dk"+ ,9>>=/ p"=:/
Kdstky+ tlc qudkoty af tlc edtd sagctogcs jdb ic ub`bawb+ dmdob+ ]rcb ct dk"+ ,9>>=/
gcbtoab tldt tlc rcputdtoab dbe jdpdiokoty af tlc jakkcjtobm dmcbjy os ogpartdbt wlcb
dsscssobm tlc qudkoty af tlc edtd tldt lds iccb pravoece" Ua mdob db obsomlt ab tlc
avcrdkk qudkoty af tlc edtd+ ot gdy ic wartl `bawobm law tlc edtd wds aromobdkky
jakkcjtce+ far cxdgpkc+ wldt sdgpkobm pkdb wds usce+ wldt edtd jakkcjtoab wds put ob
pkdjc+ ctj"
Ulc wrotcr lds td`cb tlos obta jabsoecrdtoab dbe lds usce tlc gast rcjcbt jdscstueocs ab tlc Edbosl pldrgdjcutojdk jagpdby ob arecr ta mdob d garc af db up' ta'
edtc obsomlt af tlc jagpdby dbe ots JZY prdjtoscs"
Ulc fdjt tldt Bava Bareos` os d jagpdby idsce ab rcscdrjl dbe dksa `bawb far
ldvobm d loml kcvck af trdbspdrcbjy+ ot os fdor ta sdy tldt tlc scjabedry edtd aitdobce
frag tlc jagpdby os djjurdtc"
]otlob tlc jdsc stuey rcscdrjl tlc wrotcr lds trodbmukdtce scjabedry dbe qudkotdtovcedtd frag atlcr jdsc stuey saurjcs" Iy jagiobobm gctlaes ob tlc sdgc stuey d
rcscdrjlcr jdb pdrtodkky avcrjagc ar jaubtcridkdbjc tlc ecfojocbjocs dbe iodscs tldt
fkaw frag sobmkc gctlaeakamocs" ,Gokks ct dk"+ 9>4>+ p"=5?/
Ulc eajugcbtdtoab edtd wokk jabsost af iaa`s dbe rcscdrjl pdpcrs ab Bava Bareos`
dbe law tlcy ogpkcgcbt JZY+ tlcsc scjabedry edtd rcsaurjcs drc bccece ta
ecvckap db ubecrstdbeobm af tlc jagpdbys strdtcmy ab JZY dbe law tlc jabjcpt os
ogpkcgcbtce"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
24/77
>3>59?6
95
:"3 Yckodiokoty dbe VdkoeotyYckodiokoty rcfcrs ta tlc cxtcbt ta wlojl yaur edtd jakkcjtoab tcjlboqucs ar dbdkysos
prajceurcs wokk yocke jabsostcbt fobeobms" ,Zdubecrs ct dk"+ 9>>?+ p"436/
]lokst ab tlc atlcr ldbe+ vdkoeoty rcfcrs ta tlc gctlaes tldt ldvc iccb usce ta mdob
obfargdtoab dbe wlctlcr tlc edtd os rckodikc dbe jarrcjt" Vdkoeoty ob d butslckk os
wlctlcr tlc obfargdtoab rcfkcjts tlc trutl dbe wlctlcr ot gcdsurcs wldt os ta ic
gcdsurce ,Ecbsjagic+ 9>>>+ jotce iy @ar`jlo & Yaugidut 9>>6/
Ob tlos tlcsos tlc wrotcr lds jdrcfukky poj`ce stueocs tldt ldvc iccb put tamctlcr iy
jabeujtobm obtcrvocws dbe aiscrvobm Bava Bareos`+ furtlcrgarc+ tlc sckcjtce
dutlars drc `bawb rcscdrjlcrs ob tlcor fockes af stuey dbe ldvc d mcbuobc obtcrcst ob
JZY rckdtce stueocs"
Lawcvcr+ usobm scjabedry edtd lds iccb jrotojosce icjdusc tlc uscr lds ba jabtrak
avcr tlc edtds vdkoeoty d be rckodiokoty" Xo`gube ct dk"+ ,9>49/ gcbtoab tldt dktlauml
togcky dbe pcrtobcbt scjabedry edtd gdy fot tlc rcscdrjlcrs rcquorcgcbts+ tlc edtd
jauke ic obdjjurdtc" Ulc rcscdrjl gctlaes usce ta jakkcjt tlc edtd gdy ldvc
sagclaw obtraeujce iods ta tlc edtd"
Ds prcvoausky gcbtoabce+ tlc wrotcr lds troce ta dvaoe ldvobm ba jabtrak avcr tlc
edtds vdkoeoty dbe rckodiokoty iy jlaasobm sckcjtovc stueocs" Jdsc stueocs dt Bava
Bareos` wlojl fcdturc ob Fobcmake ct dk"+ ,9>4>/ iaa` IoaObeustry Ctlojs objkuec ob
ec ptl qudkotdtovc dbdkysos af tlc ^ldrgdjcutojdk jagpdbys prdjtoscs ds wckk ds
okkustrdtobm jagpdby qucstoabbdorcs tldt drc usce wlcb sckcjtobm rcspabsoikc
suppkocrs" Lapwaae ct dk"+ ,9>4>/ wla dksa jrcdtce d jdsc stuey dppradjl ab Bava
Bareos` jkdog ob tlcor iaa` Djjaubtobm far Zustdobdiokoty 8 rdjtojdk Obsomlts tldt tlc
jdsc stueocs ldvc iccb rcscdrjlce dbe wrottcb iy d kcdeobm tcdg af kcdeobm
iusobcss dbe gdbdmcgcbt djdecgojs frag S@ dbe jabtobcbtdk Curapcdb
ubovcrsotocs wla ldvc deaptce tlc cxtcbt ta wlojl dbe law+ sustdobdiokoty
obfargdtoab lds iccb cgiceece wotl tlc rcmukdr apcrdtoabs af tlc jdsc stuey
armdbosdtoabs" ,Lapwaae ct dk"+ 9>4> + p":/ Atlcr Dutlars sujl ds Garsobm dbe
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
25/77
>3>59?6
93
Aswdke ,9>>3/ dbe ,9>>?/ wla drc djdecgojs dt tlc Japcbldmcb Iusobcss Zjlaak
dbe tlc Kabeab Iusobcss Zjlaak rcspcjtovcky ldvc dksa td`cb d sogokdr dppradjl iy
aiscrvobm dbe jakkcjtobm edtd dt tlc Edbosl jagpdby" Ob deeotoab+ tlcor rcscdrjl wds
dksa jlcj`ce iy Zusdbbc Ztargcr wla os tlc vojc'prcsoecbt af Bava Bareos`" ^drosodbe Laj`crts ,9>> Bava Bareos`
Bava Bareos` D!Z wds faubece ob 4?99 iy Dumust @raml+ d Edbosl Baick Kdurcdtc
ob plysoakamy" @raml wds obsporce iy twa Jdbdeodb rcscdrjlcrs wla lde cxtrdjtce
obsukob frag d jaws pdbjrcds" @ramls wofc lde typc 9 eodictcs dbe faubece
Bareos` Obsukobkdiardtaroug ta praeujc obsukob far eodictoj pdtocbts" Ulrcc ycdrs kdtcr+
twa fargcr jakkcdmucs af Bareos` Obsukobkdiardtaroug+ Ldrdke dbe Ularvdke ^cecrscbjrcdtce d rovdkkce obsukob jagpdby jdkkce Bava Ucrdpcutos` Kdiardtaroug" Iy 4?
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
26/77
>3>59?6
96
Ulc jagpdby spcjodkoscs ob faur tlcrdpcutoj drcds8 eodictcs+ mrawtl largabc
tlcrdpy+ largabc'rcpkdjcgcbt tlcrdpy+ dbe lcgastdsos gdbdmcgcbt ,ikaae'jkattobm
dmcbts/"
Ulc jagpdby os d wckk'`bawb kcdecr ob eodictcs jdrc tlraumlaut tlc warke wotl d
woec rdbmc af praeujts tldt objkuec obhcjtoab ecvojcs+ bccekcs+ dbe pldrgdjcutojdks"
Gujl af tlc jagpdbys sujjcss os euc ta pdtcbts ot lakes far obsukob 'eckovcry'
gctlaes+ ds tlcrc os ba pdtcbt far obsukob otsckf" ,Fobcmake ct dk"+ 9>4>+ p":>9/
Bava Bareos` bat abky lds d strabm prcscbjc ob ots bdtovc Ecbgdr` iut dksa djrass
Curapc+ ob 9>>: ot wds oecbtofoce ds tlc comltl kdrmcst pldrgdjcutojdk jagpdby dbe
jabtobucs ta mraw dbe cbtcr bcw gdr`cts" Far cxdgpkc+ Bava Bareos`-s kdtcst
obvcstgcbt rcprcscbts tlc mrawobm ob fajus ab Y&E ob tlc cgcrmobm gdr`cts"
Gdr`cts sujl ds Obeod dbe Jlobd jabtobuc ta cxpcrocbjc db objrcdsc ob eoscdsc
prcvdkcbjc ds d rcsukt af objrcdsce kofc cxpcjtdbjy dbe kofcstykc jldbmcs tldt ldvc
ajjurrce tlrauml rdpoe cjabagoj mrawtl" ,BX Eajtar+ 9>49/
Ulc Zjdbeobdvodb pldrgdjcutojdk jagpdby os d jagpdby idsce ab rcscdrjl" Ob
9>44 tlcy spcbt E@@ ?"69< gokkoab ab Y&E dbe sdkcs mrcw iy 44# ob kajdk
jurrcbjocs" ,Bava Bareos` 9>44 Dbbudk Ycpart+ p":/ Kdrs Yciocb Zrcbscb+ tlcprcsoecbt dbe JCA af Bava Bareos` gcbtoabs tldt tlos sdkcs mrawtl+ jagiobce wotl
jabtobuce fajus ab cffojocbjy af aur apcrdtoabs+ rcsuktce ob apcrdtobm prafot mrawtl af
444 Dbbudk Ycpart+ p":/
Ulc sldrc awbcrslop af Bava Bareos` cbsurcs tldt tlc armdbosdtoab lds d loml
ecmrcc af frcceag+ ds ot bat apcb far td`cavcrs+ far cxdgpkc+ frag kdrmcr
pldrgdjcutojdk jagpdbocs" ,Garsobm dbe Aswdke+ 9>>3+ p":/ Zldrc jdpotdk af tlc
jagpdby os eovoece obta D'sldrc dbe I'sldrcs+ tlc I'sldrcs drc kostce ob tlc
Japcbldmcb+ Kabeab+ dbe Bcw _ar` staj` cxjldbmcs" Ds rcpartce ob tlc 9>44
dbbudk rcpart+ Bava Bareos` I sldrcs objrcdsce iy 9"3#+ tlc dbbudk rcpart
gcbtoabs tldt tlos fomurc os ickocvce ta ic kob`ce wotl tlc ecvckapgcbt af tlc
jagpdbys sldrc projc dbe icobm d kcdecr ob tlc cvcr mrawobm eodictcs jdrc gdr`ct
ds wckk ds tlrauml cbjaurdmobm pramrcss gdec ob rcscdrjl dbe ecvckapgcbt" Ob
jabtrdst+ tlc D'sldrcs drc bab'kostce dbe lcke iy Bava D!Z ,wlojl os d provdtc kogotce
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
27/77
>3>59?6
9=
Edbosl jagpdby tldt os 4>># awbce iy tlc Bava Bareos` faubedtoab wlojl wds
cstdikoslce wotl tlc gcrmcr ob 4?
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
28/77
>3>59?6
94>+ p"946/
Ulc raats tldt kcde ta tlc jagpdbys obtcrcst rcmdreobm sustdobdiokoty jdb ic trdjce
idj` ta objoecbts tldt stdrtce ob tlc 4?=>s" Ulc jagpdby fdjce dkkcmdtoabs tldt
ectcrmcbt cbzygcs wcrc dffcjtobm tlc lcdktl af Dgcrojdb cgpkayccs wla wcrc
obvakvce ob tlc praeujtoab prajcss" Ulc rdgofojdtoabs kcde ta sdkcs ob tlc Dgcrojdb
gdr`ct ta fdkk0 tlc gdbdmcgcbt dt Bava Bareos` icjdgc fajusce ab tlc vukbcrdiokoty
af tlc iusobcss euc ta puikoj apoboab"
Ob arecr ta fox tlos praikcg+ tlc jagpdby saumlt ta rcjambosc tlc irade sct af
std`clakecrs ta wlag tlc jagpdby awce d rcspabsoiokoty ta+ dbe tlcrcfarc rcfkcjt ab
tlc ogpdjt tldt lde iccb jdusce"
Iy 4??>+ dmdob Bava Bareos` wds rcjcovobm garc bcmdtovc gceod dttcbtoab" Ulos
togc tlc gceod dttcbtoab wds diaut usobm mcbctojdkky gaeofoce armdbosgs+ tlc Edbosl
jagpdby tlos togc wds rcdey ta obotodtc d garc pradjtovc farg af std`clakecr
cbmdmcgcbt+ wlojl wds dogce dt oecbtofyobm dbe deercssobm tlc jabjcrbce ossucs
tldt lde iccb rdosce"
Lapwaae+ D" ct dk"+ ,9>4>/ paobt aut tldt tlc jagpdby sujjcssfukky pcrsudece tlasc
obvakvce ob gd`obm tlc dkkcmdtoabs ta rcvosc dbe jarrcjt tlcg dbe+ ob sa eaobm+ ta kogot
tlc cxtcbt af bcmdtovc gceod javcrdmc" ,Lapwaae+ ct dk"+ 9>4>+ p"94=/
Ulc cbmdmcgcbt kce ta cgpkayobm abc af tlc dutlars wla wds obvakvce wotl tlc
dkkcmdtoabs ab iadre+ Halb Ck`obmtab wla aromobdkky jaobce tlc tcr g tlc tropkc iattag
kobc ob 4??5" Ck`obmtab taa` d rcvocw af tlc jagpdbys iusobcss prdjtoscs+ dberckdtce tlcg ta tlc cbvorabgcbt" D ycdr kdtcr+ Bava Bareos` sct up ots forst
sustdobdiokoty strdtcmy+ wlojl fajusce ab tlc cbvorabgcbtdk jabjcrbs dt tlc togc"
Cvcr sobjc tlcy jrcdtce tlcor forst sustdobdiokoty strdtcmy idj` ob tlc ?>s+
std`clakecr cbmdmcgcbt dbe trcbe dbdkysos ldvc icjagc edoky dbe csscbtodk taaks
wlojl lckp tlc jagpdby ta oecbtofy bcw jabjcrbs tldt drc ar passoiky jauke ic
icjagc bcw gdtcrodk"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
29/77
>3>59?6
9?
Abc af tlcsc jagpdby taaks os tlc kcdrbobm jurvc+ wlojl dkombs tlc prajcsscs af
ecfobobm gdtcrodkoty wotl tlc obtcmrdtoab af tlc jagpdbys iusobcss prdjtoscs" Ossucs
af ogpartdbjc far sustdobdiokoty ob Bava Bareos` ldvc jldbmce frag d prceagobdbtky
cbvorabgcbtdk fajus ta d fajus tldt objkuecs lcdktl+ sdfcty dbe ioactlojs ossucs+ dbed fajus ab law ta obtcmrdtc ossucs af sajodk rcspabsoiokoty" ,Garsobm dbe Aswdke+
9>>3+ p"3/
Fomurc 4 slaws tlc kcdrbobm jurvc tldt Bava Bareos` uscs ta rcfkcjt law ossucs
rckdtce ta sustdobdiokoty drc icobm obtcmrdtce obta tlc iusobcss" Ztd`clakecr
cbmdmcgcbt os csscbtodk wlcb oecbtofyobm tlc rckcvdbt ossucs dbe lckps sldpc tlc
wdy tlc gdbdmcgcbt ecdks wotl tlcg" Far cvcry ossuc+ obeojdtars drc oecbtofoce ob
arecr ta trdj` dbe gabotar pcrfargdbjc+ abjc tlc rcspabsc lds iccb ecfobce"
Diavc8 Fomurc 48 Ulc Bava Bareos` Kcdrbobm Jurvc
,Jotce ob Garsobm dbe Aswdke+ 9>>3+ p"6/
Cffcjtovcky gdbdmobm std`clakecr rckdtoabs icjdgc d strdtcmoj taak far Bava Bareos`
icttcr ta ubecrstdbe tlcor pcrspcjtovcs+ dbe ta ic dikc ta dedpt ta jldbmobm sajoctdk
cxpcjtdtoabs" ,Icbbctt+ ct dk"+ 9>44+ p"9?=/ Avcr tlc ycdrs tlos lds mdobce tlc
jagpdby d vcry vdkudikc trust jdpotdk"
Lawcvcr+ ob 9>>4+ tlc Edbosl pldrgdjcutojdk faube otsckf icobm pcrjcovce ob d
bcmdtovc wdy iy tlc gceod" Ulc sotudtoab tlos togc wds ta ea wotl d Zautl Dfrojdb
jaurt jdsc avcr pdtcbt romlts0 farty atlcr pldrgdjcutojdk jagpdbocs dksa taa` pdrt"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
30/77
>3>59?6
:>
Bava Bareos`s rcputdtoab far kostcbobm ta std`clakecr jabjcrbs wds j ldkkcbmce" Ulc
jagpdby wla lde pdrtojopdtce ob tlc jdsc ta ecfcbe tlc romlts af tlc pdtcbt erums+
wlojl jdb ic sdoe ta ic tlc jarc iclobe tlc pldrgdjcutojdk iusobcss gaeck+ tlc
puikojs vocwpaobt wds tldt Bava Bareos` wds prcvcbtobm paar pcapkc fragdjjcssobm kofc sdvobm erums"
Ulc jaurt jdsc icjdgc d turbobm paobt ab law tlc jagpdby djts wotlob sajocty"
Ulos os abc sotudtoab wlcrc tlcor kcdrbobm jurvc wauke ic uscfuk dbe Bava Bareos`
eoe rcspabe ta tlc idj`kdsl tldt tlcy fdjce ob Ecbgdr` wotl rcmdres ta tlc Zautl
Dfrojdb pdtcbt romlt jdsc" Ulcy rcspabece iy obvcstobm ob d bugicr af obotodtovcs tldt
wds jrcdtce ta lckp ogpravc djjcss ta lcdktljdrc ob tlc ecvckapobm warke"
Mrubom & Lubt ,4?44+ p"9?=/
Ulc rdgofojdtoabs af tlos jldbmc frag ldvobm aromobdkky d gobesct af gdbdmobm
std`clakecrs cxpcjtdtoabs ta rcspcjtobm tlcor rakcs garc ds wckk tlc jabjcrbs tlcy
gdy ldvc ab icldkf af tlc pcapkc dbe jaggubotocs tlcy scrvc+ ds wckk ds tlccbvorabgcbt" Ulos gobe sct os bat ta ic td`cb ob sujl d pdssovc wdy+ iut dksa iy
td`cb djtoab+ dbe ubecrstdbeobm tlc rakc af ctlojs dbe ta fastcr saube ecjosoab
gd`obm"
Dt prcscbt+ icjdusc af tlcsc bcmdtovc jabbatdtoabs sujl ds tlc Zautl Dfrojdb jaurt
jdsc idj` ob 9>>4+ Bava Bareos` pravoecs obsukob rckdtce praeujts dt d vcry kaw jast
ta tlc ecvckapobm warke" Zujl objoecbjcs frag tlc pdst lds obfkucbjce tlc abmaobm
ecvckapgcbt af abc tlcor `cy taaks+ tlc tropkc iattag kobc+ dbe tlc jagpdby baw
objkuecs d sct tdrmct far tlc dgaubt af sdkcs dbe gdr`ctobm rcprcscbtdtovcs wlag
wokk ic trdobce ob tapojs sujl ds iusobcss ctlojs"
5"9 Ulc Uropkc Iattag Kobc Dppradjl
Ulc batoab af Uropkc Iattag Kobc ,:IK/ djjaubtobm lds icjagc objrcdsobmky
fdsloabdikc ob gdbdmcgcbt+ jabsuktobm+ obvcstobm+ dbe BMA jorjkcs avcr tlc kdst fcw
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
31/77
>3>59?6
:4
ycdrs" ,Bargdb dbe GdjEabdke+ 9>>5+ p"95:/ Ulc gdob oecd iclobe tlc tropkc
iattag kobc dppradjl os tldt d jagpdbys sujjcss slauke ic gcdsurce bat abky iy
tlc fobdbjodk iattag kobc+ iut dksa tlrauml sajodk dbe cbvorabgcbtdk pcrfargdbjcs"
Frag stueyobm tlc kotcrdturc rcvocw frag Jldptcr 9+ d jaggab tlcgc tldt eoe dppcdr
wds tlc batoab af std`clakecr ogpartdbjc wotl rcmdres ta JZY" Ds Bargdb dbe
GdjEabdke ,9>>5/ paobt aut+ ot os dksa d truosg tldt forgs jdbbat ic sujjcssfuk ob tlc
kabm rub of tlcy jabsostcbtky eosrcmdre tlc obtcrcsts af `cy std`clakecrs " ,Bargdb
dbe GdjEabdke+ 9>>5+ p"95:/ Ulc dppdrcbt bavckty af usobm tlc tropkc iattag kobc
stcgs frag ots suppartcr mraups sujl ds jaggubotocs+ jabsugcrs+ cgpkayccs+
suppkocrs+ ctj"+ slauke ic qudbtofoce+ jdkjukdtce+ dueotce+ dbe tlcb rcpartce ob d
jagpdbys dbbudk rcpart"
Abc af tlc garc cbeurobm jkoj ls af gaecrb gdbdmcgcbt os tldt of yau jdbt
gcdsurc ot+ yau jdbt gdbdmc ot" ,Bargdb dbe GdjEabdke+ 9>>5+ p"95:/ Ulos os abc
taak ob pdrtojukdr tldt os uscfuk far jaggubojdtobm wotl vdroaus std`clakecr mraups iy
puikoslobm sajodk+ cbvorabgcbtdk+ dbe cjabagoj pcrfargdbjcs ab db dbbudk idsos"
Garcavcr+ Z`aukaueos ct dk"+ ,9>>?/ gcbtoab tldt gdby jagpdbocs draube tlc warke
ldvc rcdkosce tldt jabvcbtoabdk fobdbjodk rcparts dbe rckdtce djjaubtobm gctlaesdkabc drc bat suffojocbt ta pravoec obfargdtoab ob obtdbmoikc dsscts dbe bab'fobdbjodk
ossucs af tlc armdbosdtoab " ,Z`aukaueos ct dk"+ 9>>?+ p"9?s+ wlcb gdbdmcgcbt tlob` '
tdb` DjjaubtDiokoty icmdb ta usc tlc ware ob ots war`" Halb Ck`obmtab ,ds prcvoausky
gcbtoabce ob 5"4/ wds iclobe tlc jabjcpt+ tlc tcrg faube puikoj jurrcbjy wotl tlc
4??= puikojdtoab af tlc Irotosl ceotoab af Halb Ck`obmtabs Jdbboidks wotl Far`s8 Ulc
Uropkc Iattag Kobc af 94 st Jcbtury Iusobcss" ,Bargdb dbe GdjEabdke+ 9>>5+ p"955/
Ulc Edbosl ^ldrgdjcutojdk uscs tlc tropkc iattag kobc dppradjl wlojl kob`s d sct af
`cy tdrmcts ta sustdobdikc dbe sajodk rcspabsoikc madks" Fomurc 9 okkustrdtcs spcjofoj
obeojdtars tldt drc usce ds wckk ds obeojdtobm tlc rcdsabs far usobm tlcg ,ogpdjt/"
Ulcrc drc sox strdtcmoj drcds tldt drc kob`ce wotl Bava Bareos` s tropkc iattag kobc
pcrfargdbjc+ tlcy objkuec8
4" Kovobm aur vdkucs0
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
32/77
>3>59?6
:9
9" Djjcss ta lcdktl0
:" Aur cgpkayccs0
5" Aur usc af dbogdks0
3" Cja'cffojocbjy dbe jagpkodbjc0 dbe6" Cjabagoj jabtroiutoab
Diavc8 Fomurc 98 Obeojdtars af tlc tropkc iattag kobc pcrfargdbjc ,Jotce ob Garsobm
dbe Aswdke+ 9>>?+ p"?:
Ulos gdob taak tldt os usce dt tlc jagpdby rcdssurcs tldt Bava Bareos` td`cs
djtoabs tldt drc jabsostcbt wotl rcspabsoikc dbe sustdobdikc icldvoaur" Garsobm dbe
Aswdke ,9>>?/ gcbtoab ob tlcor rcscdrjl tldt dkk gctrojs usce ob tlc tropkc iattag
kobc dmmrcmdtc pcrfargdbjc djrass dkk iusobcss ubots ta prcscbt tlc fukk pojturc"
,Garsobm dbe Aswdke+ 9>>?+ p"?9/
Iy usobm tlc tropkc iattag kobc+ trdbspdrcbt rcpartobm os tlcrcfarc d votdk obstrugcbt far djjaubtobm pcrfargdbjc dbe kaa`obm dt sajodk+ cbvorabgcbtdk+ dbe cjabagoj
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
33/77
>3>59?6
::
dspcjts" Zusdbbc Ztargcr+ tlc gdbdmcr af jarpardtc std`clakecr rckdtoabs quatcs
tldt tlos os wlcrc wc jdb djjaubt far aur dppradjl ta eaobm iusobcss ob d sobmkc
eajugcbt dbe jalcsovcky prcscbt pcrfargdbjc+ pramrcss+ pasotoabs+ dbe strdtcmoj
obotodtovcs ds wckk ds tlc eokcggds dbe `cy ossucs wc fdjc ds d pldrgdjcutojdkjagpdby" Gast ogpartdbtky+ wldt wc prcscbt ob tlc rcpart os tlc rcsukt af aur
obtcrdjtoabs dbe cbmdmcgcbts wotl std`clakecrs" ,Garsobm dbe Aswdke+ 9>>?+ p"?9/
5"9"4 Ulc ED]B ,Eodictcs+ Dttotuecs+ ]oslcs+ dbe Bcces/ ^ramrdggc
Db cxdgpkc af Bava Bareos` usobm ots tropkc iattag kobc dppradjl dbe obvakvobm
std`clakecr rckdtoabs jdb ic sccb frag tlc ED]B pramrdggc" Ulc pramrdggc
stdrtce ob 9>>4 wds dogce dt cxpkarobm dttotuecs dbe bcces af iatl eodictcs
suffcrcrs dbe lcdktljdrc prafcssoabdks ta kob` jrotojdk mdps ob tlc avcrdkk jurc affcrobm"
Zrcb Z`avkube+ scboar devosar af Jarpardtc Lcdktl ^drtbcrslops+ sccs tlc `cy
ckcgcbt ds tlc usc af tlc ED]B stuey ds d vclojkc ta mct dkk tlc eoffcrcbt pcapkc
raube tlc sdgc tdikcirobm pdtocbts+ lcdktl prafcssoabdks+ pdycrs+ tlc gceod
tamctlcr ta fobe bcw wdys ta war` garc cffcjtovcky tamctlcr ab tlc sdgc tds`"
,Icssdbt dbe Uoeck+ 9>44+ p"6:/
Ulc qucstoab tldt rcgdobs os wly eoe Bava Bareos` mct obvakvce1 Abc gdhar rcdsabos tldt tlc rukcs af tlc mdgc draube jlraboj eoscdsc gdbdmcgcbt drc ob fdjt sloftobm"
Icssdbt dbe Uoeck ,9>44/ stdtc far cxdgpkc+ ]LA ,]arke Lcdktl Armdbosdtoab/
cstogdtcs tldt eodictcs os d iommcr `okkcr tldb DOEZ wotl draube :"9 gokkoab ecdtls
dttroiutdikc ta tlc eoscdsc' dbe ots jagpkojdtoabs'cvcry ycdr" ,Icssdbt dbe Uoeck+
9>44+ p"6:/
Ob deeotoab+ wldt os garc dkdrgobm os tldt ob tlc ecvckapobm warke+ wlcrc abc ob tcb
ecdtls af deukts dmce :3 ta 65 drc euc ta eodictcs ,Icssdbt dbe Uoeck+ 9>44+ p"6:/+
tlcrcfarc jlraboj eoscdscs sujl ds eodictcs drc d gdhar ossuc dbe ot os sagctlobm
tldt lcdktljdrc systcgs drc objrcdsobmky fajusobm ab dbe tryobm ta gobogosc tlc
sajoa'cjabagoj iurecb af eoscdsc iy rcarmdbosobm tlc jurc prajcss dbe strujturc"
Ulcsc gdhar slofts pasc tlc ros` tldt tlc praeujt'fajusce pldrgdjcutojdk obeustry os
fdkkobm iclobe" ,Icssdbt dbe Uoeck+ 9>44+ p"65/
Ulc tropkc iattag kobc os ogpkcgcbtce frag td`obm pdrt ob tlc ED]B pramrdggc
ubecr tlc idbbcr af tlc Bdtoabdk Eodictcs ^ramrdggcs ,BE^s/" Ulcsc
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
34/77
>3>59?6
:5
pramrdggcs+ rdtlcr tldb fajusobm ab tlc praeujt soec af tlobms+ fajus ab suppartobm
ceujdtoab af lcdktl jdrc prafcssoabdks dbe iuokeobm jkobojs far eodictcs ob tlc
ecvckapobm warke far cxdgpkc"
Ulc jagpdby JCA+ Kdrs Yciocb Zrcbscb drmucs iy affcrobm dbe devajdtobm tlc
romlt sakutoabs far eodictcs jdrc wokk wc ic sccb ds d rcspabsoikc jagpdby" Of wc hust
sdy erums+ erums+ erums+ tlcy wokk sdy movc us d ircd`$ Ulos os jkcdrky maae
prdjtojc'iut tlc patcbtodk kcdvobm diaut bcw dppradjlcs ta jdrc+ cspcjodkky ubecr
rcsaurjc' jabstrdobce jabeotoabs+ dksa rcprcscbts ogpartdbt loeecb Y&E obvcstgcbt"
,Icssdbt dbe Uoeck+ 9>44+ p"65/ Ulc progdry ubecrkyobm probjopkc os ta ecvckap dbe
tcst mcbcroj pratatypc pkdbs wlojl jdb ic tcstce ob vdroaus jaubtrocs" Abc cxdgpkc
os frag Udbzdbod"
Fobcmake ct dk"+ ,9>>3/ gcbtoab tldt ta rcdjl aut icyabe tlcor jurrcbt justagcrs+
Bava Bareos`s Jarpardtc Zajodk Ycspabsoiokoty ,JZY/ pramrdgs ldvc iccb faube ab
ecvckapobm obfrdstrujturc dbe `bawkcemc ob tlc warkes paarcst jaubtrocs t a lckp trcdt
pcapkc suffcrobm frag eodictcs" ,Fobcmake ct dk"+ 9>>3+ p":4=/
Frag kaa`obm idj` dt tlc kotcrdturc rcvocw+ cspcjodkky frag 9"5"4 D vocw af JZY ob tlc
ecvckapobm warke + ot wds gcbtoabce tldt pdrtojukdrky ob Dfrojd+ JZY os jabeujtce obgarc af d plokdbtlrapoj dppradjl" Far cxdgpkc+ Srop ,9>4>/ gcbtoabce ob tlc jldptcr
tldt cstdikoslobm tlc ko`cs af jagguboty ceujdtoab sjlcgcs dbe lcdktl devojc ds
wckk ds lckpobm kajdk jaggubotocs dbe kajdk strujturcs os d jaggab JZY prdjtojc ob
tlc ecvckapobm warke"
Bava Bareos`s JZY cffarts ob Udbzdbod wcrc db cdrky pokat" Ulc obsukob
pldrgdjcutojdk icmdb war`obm wotl kajdk eodictcs dssajodtoabs ds wckk ds scttobm up
jkobojs dbe laspotdks+ trdobce stdff dbe pravoeobm rckcvdbt gceojdk cquopgcbt"
Fobcmake ct dk"+ ,9>>3/ gcbtoab tldt tlcy ldvc kcdrbce tldt ot eacsbt lckp ta hust movc
d kat af obsukob ta d jaubtry0 yau ldvc ta trdob tlc eajtars dbe burscs dbe iuoke
obfrdstrujturc" ,Fobcmake ct dk"+ 9>>3+ p":4
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
35/77
>3>59?6
:3
tlcy jdb ic ecdkt wotl kajdkky" ,Icssdbt dbe Uoeck+ 9>>4+ p"63/ Ulos pokat dppradjl
wlojl stdrtce ob tlc cdrky 9>>>s dbe tlc gavc os baw tawdres fobeobm ubeodmbasce
suffcrcrs dbe ecvckapobm dppradjlcs ta gdbdmc tlcor eodictcs ob d wdy tldt tlcy ea
bat cxpcrocbjc jagpkojdtoabs wlojl os wlcrc tlc gdhar jasts drosc frag" Ulos batabky lds ogpkojdtoabs far cxpkarobm d patcbtodk gdr`ct far obsukob iut dksa gavobm
Bava Bareos` obta d iradecr drcd af lcdktljdrc gdbdmcgcbt" Furtlcrgarc+ tlc
kcdrbobm prajcss far tlc jagpdby os diaut eoffcrcbt bdtoabdk lcdktljdrc systcgs dbe
law ta war` wotlob tlcg dbe irobm jldbmc ,sujl ds ob Udbzdbod/"
5"9"9 Zldrce Vdkuc dbe tlc Uropkc Iattag Kobc
Zusdbbc Ztargcr+ wla os tlc vojc prcsoecbt dt tlc jagpdby+ gcbtoabs ob d JZY
Curapc mcbcrdk dsscgiky cvcbt tldt tropkc iattag kobc gdbdmcgcbt os diaut vdkuc
jrcdtoab ob twa wdys+ ots diaut gobogosobm tlc eawbsoecs ,Fomurc :/ + ots diaut
gdbdmobm ros`s+ csscbtodkky ot os diaut maae lausc`ccpobm+ tldt yau drc sogpky
cxpcjtce ta ea ob gdobtdobobm tlc kojcbsc ta apcrdtc+ tlc atlcr pdrt os diaut erovobm
obbavdtoab dbe law yau jdb erovc rcvcbucs dbe law yau jdb erovc obtdbmoikc vdkucs
sujl ds rcputdtoab+ cgpkaycc cbmdmcgcbt+ ctj" ,Ztargcr+ 9>44/
Ulc jagpdbys tropkc iattag kobc dppradjl jdumlt tlc dttcbtoab af warke 'rcbawbce
iusobcss tlcarost+ Gojldk ^artcr frag tlc Ldrvdre Iusobcss Zjlaak" Ob 9>44+ Bava
Bareos` rckcdsce d puikojdtoab jdkkce Ulc Ikucprobt far jldbmc8 jldbmobm eodictcs ob
Jlobd tlc puikojdtoab os idsce ab law ta strcbmtlcb tlc lcdktljdrc systcg ds wckk
ds cstdikoslobm kajdk std`clakecr rckdtoabs wlojl drc `cy ckcgcbts af Bava Bareos`s
kabm tcrg iusobcss strdtcmy"
Maobm idj` ta Zusdbbc Ztargcrs JZY Curapc spccjl+ tlc vojc prcsoecbt gcbtoabs
tldt tlc dppradjl wc ldvc td`cb os ta try dbe dsscss law jdb wc tlcb jrcdtc dbe
jdpturc dbe jaggubojdtc wldt wc jdkk cbldbjce vdkuc+ tlc sldrce vdkuc obeojdtcs
tldt tlcrc os d poc af d jcrtdob sozc dbe wldt wc drc drmuobm os tldt wc jdb djtudkky
gd`c tlc poc iommcr" ,Ztargcr+ 9>44/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
36/77
>3>59?6
:6
Diavc8 Fomurc :8 Zldrce vdkuc usobm tlc tropkc iattag kobc ,Jotce ob Bava Bareos`
,9>44/ p"49/
Frag obfcrrobm frag Ztargcr ,9>44/ abc wdy tldt tlc jagpdby lds gdec tlc poc
iommcros iy tdrmctobm tlc ecvckapobm warke dbe usobm d plokdbtlrapoj dppradjl wotl
rcmdres ta tlcor JZY cffarts"
Garcavcr+ iy tdrmctobm drcds wlcrc jlraboj eoscdsc os pdrtojukdr loml+ tlc batoab af
sldrce vdkuc jdb ic usce ta lckp jagidt tlcsc eoscdscs dbe okkbcsscs ds wckk ds
jrcdtc db appartuboty far futurc obeustry mrawtl"
Djjareobm ta ^artcr+ jrcdtobm sldrce vdkuc os d pdbdjcd far dkk mkaidk lcdktl
jldkkcbmcs" Zagc cffarts wokk obcvotdiky eosdppaobt+ dbe gdr`ct fdokurcs wokk rcgdob"
Bcvcrtlckcss+ pldrgdjcutojdk dbe gceojdk ecvojc jagpdbocs ldvc db cxtrdareobdry
appartuboty ta lckp rceujc mkaidk suffcrobm dbe okk'lcdktl iy iuokeobm d jagpctotovc
devdbtdmc ob tlc kaw dbe goeekc objagc jaubtrocs tldt wokk ubecrpob futurc obeustrymrawtl" ,^artcr+ 9>44+ p"39/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
37/77
>3>59?6
:=
Ssobm tlos sldrce vdkuc strdtcmy ds wckk tlc tropkc iattag kobc ob ecvckapobm
jaubtrocs+ d qucstoab tldt jagcs ta gobe os law tlc gabcy os pugpce obta obvcstobm
obta ecvckapobm gdr`cts"
Ulc JCA af Bava Bareos` Kdrs Yciocb Zrcbscb gcbtoabs ob Fobcmake ct dk"+ ,9>>3/
rcscdrjl tldt lc ecfcbes tlc jagpdbys JZY obotodtovcs ta los std`clakecrs ds O lde
ta ds` aur sldrclakecrs far tlc gokkoabs far tlc Eodictcs Faubedtoab" O jdbt
mudrdbtcc d rcturb far tlcg iut wldt O eoe tckk tlcg os tldt tlc cbcrmy tlos typc af
obvcstgcbt puts obta tlc forg wokk objrcdsc aur obtcrbdk praeujtovoty0 ot objrcdscs aur
dttrdjtovcbcss ds d jagpdby ta war` far iy cgpkayccs" Ulcb tlc atlcr dspcjt+ tldt
ob tlc std`clakecrs cycs os abky spcjukdtoab+ os tldt tlc ecvckapgcbt af ecvc kapobm
jaubtrocs wokk icbcfot tlc warke ob tlc kabm' rub" ,Zrcbscb+ 9>>3+ jotce iy Fobcmake ctdk"+ 9>>3+ p":9>/ Objrcdsobm iatl sldrclakecr dbe std`clakecr trust+ Zrcbscb lds
slawb tlcg tldt tlc jagpdbys JZY obotodtovcs ea objrcdsc tlc dttrdjtoab af bc w
cgpkayccs dbe objrcdsc cgpkaycc sdtosfdjtoab"
Uaedy+ wotl tlc tropkc iattag kobc ds d iusobcss probjopkc+ Bava Bareos` td`cs d
lakostoj vocw+ scc`obm ta idkdbjc jabjcrbs far dkk std`clakecr mraups wotl
jabsoecrdtoabs af bat abky sajodk ossucs ob tlc ecvckapobm warke+ iut dksa
cbvorabgcbtdk ossucs dbe sustdobobm kabm'tcrg rcvcbucs"
Bavas sldrclakecr obtcrdjtoab dbe mkaidk ossucs jdb ic sccb ob Fomurc 5" @obma
,9>>6/ gcbtoabs diaut Fomurc 5 tldt pdrtojukdr fajus os movcb ta tlc pcapkc wlasc
lcdktljdrc bcces Bava Bareos` scrvcs" Ulraumlaut tlc vdkuc jldob std`clakecrs drc
obvakvce ob ecvckapobm garc sustdobdikc sakutoabs8 tlc armdbosdtoab war`s wotl
BMAs dbe tlc puikoj scjtar ob pdrtbcrslops+ kcdrbobm wotl std`clakecrs" ,@obma+
9>>6+ p"9?/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
38/77
>3>59?6
:/
Iy cstdikoslobm d kob` ictwccb lcdktl ds d gdob erovcr af wcdktl+ ot jdb ic vocwce
tldt ot lds iccb passoikc ta pursuc tropkc iattag kobc strdtcmocs ob d wdy tldt
objrcdsobmky tdrmcts tlc jarc af iusobcss prajcsscs'ar gd`obm tlc poc iommcr ds
Ztargcr ,9>44/ prcvoausky gcbtoabs' ob gdr`cts dbe mavcrbdbjc gcjldbosgs" Ulos
dppradjl os tlcrcfarc sldpce tlrauml cxtcbsovc std`clakecr cbmdmcgcbt pkus
cgiceeobm armdbosdtoabdk icldvoaur dbe rcspabsoikc iusobcss apcrdtoabs"
5": Ulc Idkdbjce Zjarcjdre
Ulc idkdbjce sjarcjdre os db obtcrbdk gdbdmcgcbt systcg dbe jabtdobs autjagc
gcdsurcs ob faur pcrspcjtovcs+ bdgcky fobdbjodk+ justagcr+ obtcrbdk prajcss+ ds wckk
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
39/77
>3>59?6
:?
ds kcdrbobm dbe mrawtl ta movc cgpldsos ta saft fdjtars sujl ds `bawkcemc iuokeobm+
obtcrbdk prajcss cffojocbjy dbe justagcr arocbtdtoab" ,Jlcbm+ 9>4>+ p"3/ ]ciicr dbe
Zjlffcr ,9>>>/+ @dpkdb dbe Bartab ,4??=/+ dbe Oioe ,9>>4/ gcbtoab tlc faur
pcrspcjtovcs ds8
Ulc fobdbjodk pcrspcjtovc obeojdtcs+ of tlc trdbsfargdtoab af d strdtcmy
kcdes ta ogpravce cjabagoj sujjcss" Ulus+ tlc fobdbjodk gcdsurcs
dssugc d eauikc rakc8 ab tlc abc ldbe+ tlcy ecfobc tlc fobdbjodk
pcrfargdbjc d strdtcmy os cxpcjtce ta djlocvc" Ab tlc atlcr ldbe+ tlcy
drc tlc cbepaobt af jdusc dbe cffcjt rckdtoabslops rcfcrrobm ta tlc atlcr
IZJ pcrspcjtovcs"
Ulc justagcr pcrspcjtovc ecfobcs tlc justagcr!gdr`ct scmgcbts+ ob
wlojl tlc iusobcss jagpctcs" Iy gcdbs af dppraprodtc strdtcmoj
aihcjtovcs+ gcdsurc+ tdrmcts dbe obotodtovcs tlc justagcr vdkuc
prapasotoab os rcqucstce ob tlc justagcr pcrspcjtovc+ tlrauml wlojl tlc
forg!iusobcss ubot wdbts ta djlocvc d jagpctotovc devdbtdmc ob tlc
cbvosdmce gdr`ct scmgcbts"
Ulc obtcrbdk prajcss pcrspcjtovc oecbtofocs tlasc obtcrbdk iusobcss
prajcsscs+ wlojl cbdikc tlc forg ta gcct tlc tdrmct gdr`cts dbe tlasc
af tlc sldrclakecrs"
Fobdkky+tlc kcdrbobm dbe mrawtl pcrspcjtovc ecsjroics tlc
obfrdstrujturc wlojl os bcjcssdry far tlc djlocvcgcbt af aihcjtovcs af
tlc atlcr tlrcc pcrspcjtovcs" Ob tlos jdsc+ tlc gast ogpartdbt drcds drc
qudkofojdtoab+ gatovdtoab+ dbe madk arocbtdtoab af cgpkayccs+ dbe
obfargdtoab systcgs"
,Fommc ct dk+ 9>>9+ p:/
Ulc idkdbjce sjarcjdre eostobmuoslcs otsckf frag atlcr gdbdmcgcbt taaks wotl
ots sckcjtoab af bab'fobdbjodk dbe fobdbjodk gcdsurcs+ wlojl os rckdtce iy d
jdusc'dbe'cffcjt rckdtoabslop" Ulos gdbdmcgcbt taak jaggubojdtcs d lakostoj
gaeck tldt rckdtcs ta obeovoeudk cffarts dbe djjagpkoslgcbts wotl iusobcss
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
40/77
>3>59?6
5>
ubot aihcjtovcs" Zcjabeky+ tlc idkdbjce sjarcjdre os db csscbtodk fcceidj`
systcg far jagpdbocs ko`c Bava Bareos` ta usc+ tlc devdbtdmc af tlc
idkdbjce sjarcjdre os tldt ot cbjaurdmcs cgpkayccs ta jabsoecr tlc ogpdjt af
tlcor ecjosoabs ab prafotdiokoty ,Zgotl dbe @og+ 9>>3+ p"=>/Furtlcrgarc+ tlcy dksa gcbtoab tldt atlcr devdbtdmcs drc bat hust kajdkosce
dbe fajusce ob tlc slart tcrg" Ds cdjl ecpdrtgcbt rcdjlcs ots madk,s/+ ot dksa
lckps tlc cbtorc jagpdby icjagc jkascr ob dttdobobm ots tdrmcts" Ulc idkdbjce
sjarcjdre gctlae tlcrcfarc ogpravcs dkombgcbt dgabm eovosoabdk ar obeovoeudk
madks ds wckk ds tlc jagpdbys madks dbe strdtcmocs"
Kob`obm tlc idkdbjce sjarcjdre wotl lcdktljdrc+ Doecgdr` ,9>>4/ stdtcs tldt
gdbdmcrs ob lcdktljdrc drc obsporce dt scgobdrs+ jabfcrcbjcs+ dbe jaurscs
iy jabsuktdbts ta gaecrbosc tlcor gdbdmcgcbt djjaubtobm systcg usobm tlc
bcw gordjukaus trcdtgcbt af tlc idkdbjce sjarcjdres" ,Doecgdr`+ K"M"+
9>>4+ p"9:/
^rafcssoabdks ob tlc gceojdk obeustry scc tlc passoiokoty af usobm tlc idkdbjce
sjarcjdre ta put tlc ko`cs af pdtocbts+ prajcss+ dbe cgpkayccs ta tlc farc"
Lcdktljdrc armdbosdtoabs ldvc tlc frcceag ta ecsomb d idkdbjce sjarcjdre ob
dby wdy tldt gccts tlc armdbosdtoabs bcces+ iut d idkdbjce sjarcjdre far d
lcdktl jdrc scjtar gust dttcgpt ta djjugukdtc tlc bcces af gdby
armdbosdtoabs tlus+ lcdktljdrc armdbosdtoabs jdb jlaasc obeojdtars tldt rcfkcjt
tlcor awb spcjofoj gossoab+ scrvojcs+ dbe pramrdgs+ dbe apcrdtobm
cbvorabgcbt" ,Xckgdb ct dk"+ 9>>:+ p"4>/
Garsobm dbe Aswdke ,9>>3/ ecsjroic tlc idkdbjce sjarcjdre dt Bava
Bareos` ds Ulc Idkdbjce sjarcjdre os tlc gdbdmcgcbt taak far cgiceeobm
dbe jdsjdeobm tlc tropkc iattag kobc dppradjl tlraumlaut tlc armdbosdtoab"
Ulc sjarcjdre os d votdk ckcgcbt af tlc jarpardtc mavcrbdbjc sct'up ob Bava
Bareos` dbe tlus d vcry pawcrfuk taak ta cbsurc obtcmrdtoab af tlc
sustdobdiokoty dppradjl obta dkk iusobcss prajcsscs" ,Garsobm dbe Aswdke+
9>>3+ p"4>/
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
41/77
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
42/77
>3>59?6
59
Diavc8 Fomurc 38 Db cxdgpkc af law tlc idkdbjce sjarcjdre jdsjdecs ,Jotceob Garsobm dbe Aswdke+ 9>>3+ p"4:/
Ulc diavc cxdgpkc slaws law tlc idkdbjc sjarcjdre troj`kcs eawb frag tlc
jarpardtc soec romlt eawb ta tlc eodictcs foboslce praeujts" Ssobm tlc
eodictcs foboslce praeujts tcdg ds db cxdgpkc+ fargdk gabotarobm td`cs pkdjc
ab d gabtlky idsos+ edtd ab dkk @^O s ,@cy ^crfargdbjc Obeojdtars/ drc tlcb
jdkjukdtce dbe upedtce ab tlc jagpdbys O"U" systcg" Cdjl sotc gdbdmcr dt
Bava Bareos` lds ta prcpdrc d gabtlky rcpart tldt cxpkdobs dby ecvodtoabs
frag tlc sct tdrmcts" Furtlcrgarc+ dby kdrmc ecvodtoab tldt tlc systcg paobtsaut lds ta ic dbswcrce wotl d spcjofoj djtoab pkdb" Obfargdk gcctobms dksa
td`c pkdjc0 tlc purpasc af tlcsc gcctobms os ta rcfkcjt ab pcrfargdbjcs dbe ta
scc of tlcor tdrmcts tlcy ldvc fargukdtce ldvc mabc djjareobm ta pkdb+ dbe of
bat wly"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
43/77
>3>59?6
5:
Db csscbtodk pdrt af tlc sjarcjdre os tldt ot os db ogpartdbt fcceidj` taak+ @dpkdb dbe
Bartab ,9>>=/ quatc tldt d strdtcmoj fcceidj` systcg slauke ic dikc ta tcst+
vdkoedtc+ dbe gaeofy tlc lypatlcsos cgiceece ob d iusobcss ubots strdtcmy" ,@dpkdb
dbe Bartab+ 9>>=+ p"4>6/ Iy cstdikoslobm iatl slart tcrg dbe kabm tcrg madks+ wotlobtlc pkdbbobm prajcss+ cxcjutovcs drc tlcrcfarc dikc ta farcjdst rckdtoabslops ictwccb
jldbmcs ob pcrfargdbjc erovcrs dbe tlc dssajodtce jldbmcs ob tlc sct madks"
5"5 Fdjokotdtoab
Fdjokotdtoab os jabeujtce iy d sgdkk tcdg af vcry cxpcrocbjce stdff gcgicrs+ usudkky
tlos sgdkk tcdg os jlascb iy scboar gdbdmcrs wotlob tlc jagpdby" Uds`s objkuecdsscssobm iusobcss ubot pcrfargdbjcs ob jagpkodbjc wotl tlc fubedgcbtdks dbe
vdkucs af Bava Bareos`s jldrtcr+ tlcy oecbtofy dbe sldrc icst prdjtoscs djrass tlc
jagpdby iy jakkcjtobm cvoecbjc frag tlc soxty ar sa fdjokotdtars tldt drc td`cb pcr
dbbug dbe praeujc d rcpart tldt os suigottce ta tlc cxcjutovc gdbdmcgcbt tcdg"
Lapwaae+ D" ct dk"+,9>4>/ quatc tldt tlc gctlaeakamy af tlc fdjokotdtars ob dkk tlc
diavc tds`s os gujl kcss qudbtotdtovc ob dppradjl tldb UIK rcpartobm ar idkdbjce
sja rcjdres" ,Lapwaae+ ct dk"+ 9>4>+ p"99
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
44/77
>3>59?6
55
tlc jagp dby lds ecvosce" ,Lakecb+ B" + 9>>9 p"4:>/ Ob deeotoab+ tlc jagpdby jdb
jcrtdobky ic mrdtcfuk tawdres tlc fdjokotdtars far raatobm aut gdkprdjtojcs tldt dffcjtce
Bava Bareos` warkewoec"
Far cxdgpkc+ ob d jcrtdob jaubtry+ twa fdjokotdtars wcrc dikc ta ubcdrtl d gdkprdjtojc
tldt wds bat abky d ircdjl tawdres tlc jagpdbys jaec af jabeujt+ iut dksa d
pubosldikc affcbjc ob tldt jaubtry" Ulc pdrtojukdr jaec af jabeujt wds wckk `bawb ta
Bava Bareos`+ dbe far tlc forst togc tlc jagpdby wds dikc ta oecbtofy law tlos
gdkprdjtojc wds icobm jaggottce" Abjc dkk af tlos obfargdtoab lde iccb scbt ta tlc
jagpdbys Japcbldmcb lcdequdrtcrs iy tlc fdjokotdtars+ d gcctobm wotl dkk tlc
scboar gdbdmcrs tldt wcrc rcspabsoikc far rcmoabdk iusobcsscs wcrc oggceodtcky
jdkkce"
Ulc rcsukt kce ta Bava Bareos` td`obm jarpardtc djtoab ta stdgp aut tlos sjdg" Ot jdb
ic sdoe tldt fdjokotdtoab os d prafaube kcdrbobm cxpcrocbjc0 abc fdjokotdtar stdtce tldt
tlc kcdrbobm cxpcrocbjc wds ko`c d rcdk kofc GID+ icjdusc icobm d fdjokotdtar
cxpascs yau ta cvcry ogdmobdikc iusobcss sotudtoab" ,Lakecb dbe Mkosiy+ 9>4>+
p"4?5/
Ulcsc gdby taaks tldt Bava Bareos` uscs ecfobotcky movcs d kcdrbobm cxpcrocbjc+wlctlcr ots iy usobm tlc idkdbjce sjarcjdre ar iy usobm fdjokotdtars+ ob deeotoab
fakkawobm tlc Bava Bareos` ]dy af Gdbdmcgcbt ,wlojl wokk ic eosjussce ob 5"3/ dbe
gd`obm surc gcgicrs af stdff ubecrstdbe ot os csscbtodk wotl rcmdres ta law tlc
jagpdby jabeujts ots iusobcss prdjtoscs"
5"3 Bava Bareos` ]dy af Gdbdmcgcbt Ulc Bava Bareos` ]dy af Gdbdmcgcbt lds iccb usce sobjc tlc kdtc 4??>s dbe os d
frdgcwar` tldt os ecsombce ta bdvomdtc tlc wdy ob wlojl cvcry jagpdby cgpkaycc
dbe gdbdmcr war`s draube tlc warke" Ulos frdgcwar` jabsosts af tlrcc pdrts+ Ulc
Vosoab+ Ulc Jldrtcr+ dbe ^akojocs"
Ulc forst pdrt tlc vosoab+ cxpkdobs wldt tlc jagpdby wdbts ta djlocvc dbe tlc avcrdkk
madks tldt rckdtc ta pdtocbts+ sajocty+ dbe tlcor gcgicrs af stdff" Ulc vosoab stdtcs
tldt wc wokk ic tlc warkes kcdeobm eodictcs jagpdby" ]c wokk affcr praeujts dbe
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
45/77
>3>59?6
53
scrvojcs ob atlcr drcds wlcrc wc jdb gd`c d eoffcrcbjc" ]c wokk djlocvc jagpctotovc
iusobcss rcsukts" D hai lcrc os bcvcr hust d hai" Aur vdkucs drc cxprcssce ob dkk aur
djtoabs" Aur lostary tckks us+ ot jdb ic eabc" ,Zalg+ 9>>=+ p"49/
Ulc scjabe scmgcbt+ Ulc Jldrtcr+ objkuecs d ecjkdrdtoab af Bava Bareos`s vdkucs
tldt drc djjaubtdikc+ rcspabsoikc+ dgiotoaus+ cbmdmc wotl ots std`clakecrs+ ds wckk
icobm apcb dbe labcst+ pkus ta ic apcb ta jldbmc" Ob deeotoab+ tlc jldrtcr dksa
objkuecs tlc pldrgdjcutojdk jagpdbys jaggotgcbts ta icobm fobdbjodkky
rcspabsoikc+ cbvorabgcbtdkky rcspabsoikc+ dbe sajodkky rcspabsoikc ,tlc tlrcc pdrts af
tlc tropkc iattag kobc/"
Ulc fubedgcbtdks os d kost tldt cdjl ubot dbe tcdg gust dioec iy" Ulc jldrtcr muoecs
dkk jagpdbocs tldt drc dssajodtce wotl tlc Bava Mraup+ dbe tlc cgpkayccs jaggot
ta war`obm wotlob tlos muoece frdgcwar`" Ulc tlore jrotcrod+ pakojocs+ okkustrdtc maae'
prdjtojc dbe ctlojdk muoedbjc rcmdreobm spcjofoj apcrdtoabdk ossucs wotlob tlc
fakkawobm drcds8 tlc cbvorabgcbt+ jaggubojdtoab+ fobdbjc+ lcdktl dbe sdfcty+ O"U"+
pcapkc+ kcmdk+ qudkoty+ purjldsobm+ ros` gdbdmcgcbt+ mkaidk lcdktl+ dbe ioactlojs"
Cdjl movcb pakojy cxpkdobs wldt ot wokk ea dbe law ot wokk ic eabc" Kaa`obm dt tlcioactlojs pakojy far cxdgpkc+ Bava Bareos` dogs ta jabtobuausky ogpravc ioactlojdk
pcrfargdbjc" Ulos gcdbs tlc jagpdby wokk8
^ragatc ioactlojdk dwdrcbcss tlraumlaut tlc jagpdby
Cstdikosl dbe cbsurc loml ctlojdk stdbedres far8
4/ Cxpcrogcbts ab kovobm dbogdks9/ Jkobojdk trodks dbe usc af lugdb gdtcrodk:/ Mcbc tcjlbakamy
Zct loml ctlojdk stdbedres far aur cxtcrbdk pdrtbcrs+ jabtrdjt rcscdrjlarmdbozdtoabs dbe suppkocrs dbe gabotar tlcor pcrfargdbjc
Cbmdmc ob std`clakecr eodkamuc dbe pdrtbcrslops dbe rcpart ab aur
pcrfargdbjc
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
46/77
>3>59?6
56
Kovc up ta tlc sporot+ vdkucs+ probjopkcs+ dbe jabtcbt af rckcvdbt jabvcbtoabs+kdws dbe rcquorcgcbts
,Fobcmake ct dk"+ 9>>3+ p":>>3+ p"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
47/77
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
48/77
>3>59?6
549+ p":=:/ Ua dvaoe eosjrogobdtobm prdjtoscs wlcb lorobm bcw jdbeoedtcs+
gdbdmcrs dt Bava Bareos` Gcxoja sckcjt tlcor patcbtodk cgpkayccs idsce ab tlcor
hai prafokc"
Fobcmake ct dk"+ ,9>>3/ gcbtoab tldt eurobm tlc rcjruotgcbt prajcss+ Bava Bareos`
pdys pdrtojukdr dttcbtoab ta wlctlcr tlc jdbeoedtc wokk fot wotl tlc jagpdbys jukturc
dbe bat hust ic dikc ta pcrfarg wckk tcjlbojdkky" ,Fobcmake ct dk"+ 9>>3+ p":4>/ Ulc
rcjruotgcbt dbe sckcjtoab gdbdmcr dt Bava Bareos` Gcxoja cxpkdobs tldt wc ldvc
djjcss ta tlc gdob LY apcrdtoabdk prajcsscs af tlc forg0 lawcvcr wc bccece ta
dedpt ot ta tlc Gcxojdb kcmoskdtoab" Lawcvcr+ Bava Bareos`s plokasaply os
jagpkctcky eoffcrcbt frag Ptldt afW atlcr jagpdbocs tldt O ldvc war`ce far ,SZD dbe
Gcxoja/" Baw+ O ldvc ta gd`c surc tldt tlcrc os ba eosjrogobdtoab ob dby af aur LY
suisystcgs" ,Ldytab ct dk"+ 9>49+ pp" :=:+:=5/
Ulc plokasaply cbjagpdsscs tlc armdbosdtoabdk vdkucs dbe jukturc tldt Bava
Bareos` trocs ta jrcdtc draube tlc warke dbe gd`c surc cgpkayccs dkomb tlc BavaBareos` ]dy af Gdbdmcgcbt ob tlcor cvcryedy war`obm cbvorabgcbt" Ulc LY
gdbdmcr dt Bava Bareos` Gcxoja jaggcbts djrass Bava Bareos`+ wc drc war`obm
ldre ta ogpkcgcbt d kcdrbobm jukturc ta lckp pcapkc iuoke bcw jagpctcbjocs quoj`ky"
,Ldytab ct dk"+ 9>49+ p":=3/ Ot jdb ic obfcrrce tldt tlc Edbosl pldrgdjcutojdk
jagpdbys jldkkcbmc ob Gcxoja os ta gd`c surc tldt tlc cgpkayccs ubecrstdbe dbe
ickocvc tlc jagpdbys vdkucs dbe ta cbjaurdmc tlcg ta deapt tlcsc vdkucs frag
usobm tlc Bava Bareos` ]dy af Gdbdmcgcbt"
Ulc JCA Kdrs Yciocb Zrcbscb cxpkdobs law tlos os pcrjcovce eurobm db obtcrvocw
wotl tlc Curapcdb Iusobcss Farug+ wc ldvc d eostobjt jukturc icjdusc wc drc
dkombce jkascky wotl aur aromob" ]c ldvc d sajodk rcspabsoiokoty0 wc ldvc rcspcjt far
tlc obeovoeudk" Ots batlobm Edbosl atlcr tldb wc ldvc db obirce ubecrstdbeobm tldt
jagpdbocs jdbbat apcrdtc ob d vdjuug+ dbe wc ecpcbe ab sajocty dbe wc bcce ta
gd`c d jabtroiutoab ta ic dikc ta cxost kabm' tcrg" ,Zjlokkcr+ 9>>=+ p"3
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
49/77
>3>59?6
5?
5"6 Jdusdk Gdps
Frag kaa`obm idj` dt tlc kotcrdturc rcvocw+ ot jdb ic sdoe tldt Bava Bareos` td`cs d
scbscgd`obm dppradjl wotl rcmdres ta ots JZY cffarts" Ds prcvoausky gcbtoabce ob
tlc kotcrdturc rcvocw+ djjareobm ta Idsu dbe ^dkdzza ,9>>
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
50/77
>3>59?6
3>
^dmc 5?8 Fomurc =8 Ztd`clakecr Gdbdmcgcbt dt Bava Bareos` ,jotce ob ^droso dbeLaj`crts+ 9>>
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
51/77
>3>59?6
34
af gdp rcprcscbts d jagpkctc rcprcscbtdtoab af d sajodk systcg+ dbe tlcrcfarc
dkkaws dkk vocwpaobts ta ic rcprcscbtce" Ob jabtrdst+ Bdrdydbdb dbe Drgstrabm
,9>>3/ eosdmrcc dbe sdy tldt tlc dmmrcmdtc dppradjl eacs bat cgpldsozc tlc
jdusdk kaaps ob tlc jakkcjtovc gdp" Far tlos rcdsab+ ot gdy bat pravoec d fukkrcprcscbtdtoab af sajodk systcgs+ icjdusc typojdkky sajodk systcgs jabsost af gdby
djtars wotl sombofojdbtky eovcrsc vocwpaobts" ,Bdrdydbdb dbe Drgstrabm+ 9>>3+
p"453/Ulc scjabe typc af gdppobm+ jabmrcmdtc gdppobm+ tlos dppradjl jcbtrcs ab
tlc oecbtofojdtoab af `cy jdusdk kaaps tldt erovc systcg eybdgojs" ,Iaumab+ 4??9+
jotce iy Udtojjlo+ 9>4>+ p"44?/ Ulc oecd iclobe tlos pdrtojukdr typc af gdppobm
systcg os tldt strcsscs jdusc'dbe'cffcjt rckdtoabslops" Udtojjlo ,9>4>/ paobts aut tldt
tlcsc gdps drc sogpkcr tldb tlc sug af obeovoeudk gdps+ sa tldt dkk passoikc
jabfkojtobm vocws af tlc sajodk systcg drc bat fukky rcprcscbtce" ,Udtojjlo+ 9>4>+
p"44?/ Furtlcrgarc+ Bdrdydbdb dbe Drgstrabm ,9>>3/ strcss tldt tlcsc jdusdk kaaps
drc votdk ds tlcy obeojdtc d sajodk systcgs oecbtoty dbe jldbmc ds wckk ds tlc
systcgs jagpkcx icldvoaurs" Kdstky+ tlc war`slap gdppobm prajcss fajuscs ab d
jabscbsudk frdgcwar` wlojl os put tamctlcr dt d mraup kcvck" ]ar`slaps+ ar mraup
gcctobms+ drc wlcrc tlc gaeck os iuokt iy dkk pdrtojopdbts+ doece iy tlc fdjokotdtar ,tlc
rcscdrjlcr/ wlasc rakc os jcbtrdk far tlc sujjcss af tlc scssoab" ,Udtojjlo+ 9>4>+
p"44?/ Ulos typc af dppradjl os gdobky suotdikc far sgdkkcr mraups dbe bat
rcjaggcbece far kdrmc mraups ar armdbosdtoabs ds ot prcscbts d kogot af suihcjtovoty+
lawcvcr tlos dppradjl jdb ic usce dkabc ar jagiobce wotl atlcr gctlaes ta
ogpravc d sldrce cffart af jakkcjtovc gdppobm" Atlcr rcscdrjlcrs ,Dj`crgdbb ct dk"+
4??=0 Eoffcbidjl+ 4?
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
52/77
>3>59?6
39
ta iuokeobm std`clakecr trust dbe dogce dt rceujobm iusobcss ros`s+ objrcdsobm
apcrdtoabdk cffojocbjy+ pursuobm praeujt eoffcrcbtodtoab ds wckk ds jrcdtobm d bcw
gdr`ct spdjc"
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
53/77
>3>59?6
3:
Diavc8 Fomurc >
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
54/77
>3>59?6
35
5"6"4 Yceujobm Iusobcss Yos`
Gdby sjlakdrs ldvc ubecrkobce tlc fdjt tldt d pradjtovc stdbjc ab jarpardtc sajodk
rcspabsoiokoty os aftcb tlc rcsukt af d jagpdby strdtcmy dogce dt rceujobm tlc kcvck af
jarpardtc ros`" ,Edvoe+ 4?=:0 Eykkoj`+ 4???0 Ycobldret+ 9>>>0 _dzoho+ 9>>50 jotce iy^droso dbe Laj`crts+ 9>>>49/
Garcavcr+ Bava Bareos` MGA cxpcrt @bue Vde stdtcs tldt wc icldvc ob apcbbcss
wlcb wc ecdk wotl ossucs wlojl jdusc puikoj jabjcrb wc scc ot ds aur aikomdtoab ta
jaggubojdtc ab dby ossuc wotl d pcrjcovce ros` ta sajocty" ,Bava Bareos`+ 9>49/
Abc gdob erovcr far Bava Bareos`s cbmdmcgcbt ob JZY rckdtce djtovotocs avcr tlc
ycdrs sccgs ta ldvc iccb idsce draube gceod dttcbtoab0 pdrtojukdrky tlc ros` af BMAs jdgpdombobm dmdobst tlc pldrgdjcutojdk modbt"
Jdgpdomb ros` rcfcrs ta tlc passoiokoty af icobm dttdj`ce iy BMAs ds icobm
rcprcscbtdtovc af d wlakc scjtar" ,Laj`crts+ 9>>6/ _dzoho ,9>>5/ gcbtoabs ob los
rcscdrjl pdpcr Uawdre d tlcary af sajodk ros` tldt tlos prceagobdbtky ajjurs of d forg
os tlc gdr`ct kcdecr cvcb of ot os bat tlc warst affcbecr ob tlc obeustry" Kob`obm tlos
wotl Bava Bareos`+ tlc jagpdbys obtcrcst wotl rcmdres ta mkaidk lugdb romlts far
cxdgpkc+ icobm tlc gdr`ct kcdecr ob obsukob+ tlc jagpdby fdjcs tlc ros` af icobm
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
55/77
>3>59?6
33
sobmkce aut iy mavcrbgcbtdk dbe bab'mavcrbgcbtdk armdbosdtoabs ab ossucs tldt
jabjcrb lugdb romlts djrass tlc suppky jldob"
5"6"9 Objrcdsce Apcrdtoabdk Cffojocbjy
Iuokeobm ab tlc cjabagoj kdw af eogoboslobm rcturbs+ pdst rcscdrjl lds cgpldsozce
tldt dby eauikc eovoecbes tldt forgs gdy aitdob frag cbvorabgcbtdk gdbdmcgcbt drc
ko`cky ta eogobosl fdst" ,Laj`crts+ 9>>6+ p"45/ Ulc oecd ds ^dkgcr ct dk"+ ,4??3/ dbe
]dkkcy ct dk"+ ,4??5/ put ot ds tldt tlcrc drc abky d kogotce bugicr af ldbmobm fruot"
Abjc tlcsc ldvc iccb ldrvcstce forgs jdb ba kabmcr cxpcjt jast devdbtdmcs frag
pradjtovc JZY gcdsurcs" ,^dkgcr ct dk"+ 4??30 ]dkkcy ct dk"+ 4??50 jotce iy
Laj`crts+ 9>>6+ pp"45+43/
Lawcvcr+ ^droso dbe Laj`crts ,9>>
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
56/77
>3>59?6
36
Appartubotocs wcrc td`cb ta eoffcrcbtodtc praeujts ab cotlcr d sajodk ar cbvorabgcbtdk
kobc"
Zobjc pdtocbts+ eajtars+ dbe atlcr prafcssoabdks ob lcdktljdrc systcgs sccg ta ic
jabsoecrce ds tlc gdob obeojdtars far JZY rckdtce djtovotocs+ tlc jagpdby eospkdys d
strabm cbearscgcbt af tlos pakojy" ,^droso dbe Laj`crts+ 9>>
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
57/77
>3>59?6
3=
Djjcss ta lcdktljdrc ob tlc ecvckapobm warke os d jaggab tlcgc+ wotl d loml ogpdjt
ab tlc obeustrys rcputdtoab" Ot wds cgcrmce frag ^droso dbe Laj`crts obtcrvocwcc
fobeobms tldt Bava Bareos` os djtovcky cbmdmobm ob pravoeobm eodictcs jdrc ob tlc
ED]B prahcjt drcds sujl ds Udbzdbod+ iy pravoeobm d icttcr djjcss ta lcdktljdrcds wckk ds trdobobm burscs dbe eajtars" ^rdldkde ,9>>6/ gcbtoab ob los iaa` Ulc
Fartubc dt tlc iattag af tlc pyrdgoe + tldt ds tlc jaubtry ,Udbzdbod/ os dikc ta dffare
forst jkdss eodictcs jdrc+ tlc jagpdby wokk ldvc iccb d pdrtbcr ob tlc puikoj
lcdktljdrc systcg far sagc togc0 tlos wokk tlcrcfarc ldvc d jabsoecrdikc devdbtdmc
avcr ots jagpctotars" ,^rdldkde+ 9>>6/
Ulc rcscdrjl dksa obeojdtce wotl rcmdres ta jrcdtobm d bcw gdr`ct spdjc tldt
mrccblausc mdscs drc d gdhar ossuc+ tlcrcfarc+ tlc jagpdby os obvcstobm obrcbcwdikc saurjcs sujl ds wobe pawcr" Zogokdr pramrdggcs ldvc iccb put ob pkdjc
dogobm ta rceujc cbcrmy rcsaurjcs dbe icobm garc cbvorabgcbtdkky frocbeky"
Jldptcr 3 ' Fobeobms
3"> Fobeobms
Frag kaa`obm dt dutlars sujl ds Garsobm+ dbe Aswdke ,9>>3/ dbe ,9>>?/+ Fobcmake
ct dk"+ ,9>>3/+ ^droso dbe Laj`crts ,9>>4>/ ot os jkcdr ta
scc wotl dkk tlc taaks Bava Bareos` uscs+ tldt ot os d jagpdby tldt td`cs JZY vcry
scroausky"
Lawcvcr+ ab d prdjtojdk kcvck+ abc tlobm tldt wds batojce os tlc eoffojuktocs ob
cgiceeobm JZY wotl rcmdres ta tlc jagpdbys fajus ab iatl qudkotdtovc dbe jukturdk
eogcbsoabs af gdbdmcgcbt" D quatc frag d gcgicr af tlc bab'fobdbjodk edtd
gdbdmcgcbt tcdg gcbtoabs tldt O pcrsabdkky tlob` tldt tlcrc drc sagc idrrocrs ta
fukk obtcmrdtoab+ dbe idrrocrs ob aur ,bab'fobdbjodk edtd gdbdmcgcbt/ ecpdrtgcbts
tawdres tlc fobdbjodks" O scc jldkkcbmcs dlcde ob rckdtoab ta d jaggab
ubecrstdbeobm dbe kdbmudmc ictwccb tlc fobdbjodk dbe tlc bab'fobdbjodk pcapkc+ d
wlakc jukturdk tlobm+ d wdy af tlob`obm" Ulos os diaut twa eoffcrcbt warkes+ iut af
jaursc+ wc scc tlc purpasc af cdjl atlcr" ]crc hust bat ab tlc sdgc pdmc ob tcrgs
-
7/23/2019 CSR in the pharmaceutical industry : The case study of Novo Nordisk
58/77
>3>59?6
34>+ p"995/
Ot sccgs tldt tlcrc drc d fcw idrrocrs ds tlc gcgicr af tlc bab 'fobdbjodk tcdg put
ot+ far cxdgpkc+ fukky dkombobm iatl tlc fobdbjodk dbe bab'fobdbjodk gcjldbosgs wokk
rcquorc jakkcjtobm qudkotdtovc edtd ab d gabtlky idsos+ Lapwaae+ ct dk"+ ,9>4>/
gcbtoabce tldt far gdby sujl gcdsurc lds bcvcr iccb tlc jdsc" Furtlcrgarc+
dbatlcr tlobm tldt lds iccb batojce wds tlc ossuc af tlc @^Os ,@cy ^crfar gdbjc
Obeojdtars/ dbe tlc jabsostcbjy af tlcsc tdrmcts" Ulos lds iccb rcjambosce iy tlc
jagpdby+ ds tlc Zcboar Vojc' ^rcsoecbt far Fdjokotdtoab stdtcs tldt wc jauke ic garc
strujturce ob tlc wdy wc ecfobc aur @^Os 'bat hust taedy iut tlrcc ar fovc ycdrs
dlcde" Kabm tcrg tdrmcts sldrclakecrs jdb fakkaw tlcg dbe cstdikosl prapcr cxpcjtdtoabs" ,Zcboar Vojc rcsoecbt far Fdjokotdtoab+ jot ce iy Lapwaae+ ct dk"+ 9>4>+
p"99=/
Ulc jagpdbys idkdbjce sjarcjdre dksa lds ots jrotojosgs" Ulcrc sccgs ta ic abky d
f cw sustdobdikc drcds tldt drc eorcjtky kob`ce wotl Bavas sjarcjdre+ sujl ds
cbvorabgcbtdk+ eovcrsoty dbe tdkcbt ecvckapgcbt" Ob deeotoab+ tlc qucstoab rcgdobs ab
law fdr eawb tlc locrdrjly tlc idkdbjce sjarcjdres drc djtudkky ogpkcgcbtce" Bava
Bareos` jauke ecvckap d sustdobdikc idkdbjce sjarcjdre ,ZIZJ/ tldt cgirdjcs
cjabagoj+ cbvorabgcbtdk+ dbe sajodk pcrspcjtovcs" Ulc ZIZJ cgices tlc tropkc
iattag kobc dppradjl wotlob tlc fdgokodr idkdbjce sjarcjdre frdgcwar`+ gd`obm ot
cdsocr ta jaggubojdtc dbe ogpkcgcbt" ,Luiidre+ 9>>?+ p"4/ Lc dksa paobts aut ob los rcscdrjl ab deaptobm d
sustdobdikc idkdbjce jdre tldt tlos wokk rcquorc jagpdbocs ta deapt d std`clakecr
vocwpaobt af vdkuc dbe jrcdtc str
top related